{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:21:23Z","timestamp":1793744483886,"version":"4.6.1"},"reference-count":400,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BrightFocus Foundation (US)","award":["A2013328S00"],"award-info":[{"award-number":["A2013328S00"]}],"id":[{"id":"https:\/\/ror.org\/03cvfxv40","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Cheryl and Haim Saban Foundation"},{"name":"The Marciano Family Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00018-017-2463-7","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T06:40:51Z","timestamp":1487054451000},"page":"2167-2201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":274,"title":["Clearance of cerebral A\u03b2 in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes"],"prefix":"10.1007","volume":"74","author":[{"given":"Leah","family":"Zuroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-8442","authenticated-orcid":false,"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"issue":"19","key":"2463_CR1","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","volume":"80","author":"LE Hebert","year":"2013","unstructured":"Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census. Neurology 80(19):1778\u20131783. doi: 10.1212\/WNL.0b013e31828726f5","journal-title":"Neurology"},{"key":"2463_CR2","unstructured":"Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M (2015) World Alzheimer Report 2015: the global impact of dementia. Alzheimer\u2019s Disease International, London"},{"issue":"5594","key":"2463_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298(5594):789\u2013791. doi: 10.1126\/science.1074069","journal-title":"Science"},{"issue":"2","key":"2463_CR4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81(2):741\u2013766","journal-title":"Physiol Rev"},{"issue":"29","key":"2463_CR5","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","volume":"289","author":"BB Holmes","year":"2014","unstructured":"Holmes BB, Diamond MI (2014) Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J Biol Chem 289(29):19855\u201319861. doi: 10.1074\/jbc.R114.549295","journal-title":"J Biol Chem"},{"issue":"7465","key":"2463_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501(7465):45\u201351. doi: 10.1038\/nature12481","journal-title":"Nature"},{"issue":"6","key":"2463_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608. doi: 10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"2463_CR8","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1038\/ncomms4867","volume":"5","author":"G Meli","year":"2014","unstructured":"Meli G, Lecci A, Manca A, Krako N, Albertini V, Benussi L, Ghidoni R, Cattaneo A (2014) Conformational targeting of intracellular Abeta oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum. Nat Commun 5:3867. doi: 10.1038\/ncomms4867","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"2463_CR9","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage 54 Suppl 1:S204\u2013217. doi: 10.1016\/j.neuroimage.2010.06.020","journal-title":"NeuroImage"},{"issue":"1\u20134","key":"2463_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000335154","volume":"10","author":"Y Koronyo","year":"2012","unstructured":"Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M (2012) Alzheimer\u2019s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment. Neurodegener Dis 10(1\u20134):285\u2013293. doi: 10.1159\/000335154","journal-title":"Neurodegener Dis"},{"issue":"1","key":"2463_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, Sambati L, Pan BX, Tozer KR, Barboni P, Provini F, Avanzini P, Carbonelli M, Pelosi A, Chui H, Liguori R, Baruzzi A, Koronyo-Hamaoui M, Sadun AA, Carelli V (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 79(1):90\u2013109. doi: 10.1002\/ana.24548","journal-title":"Ann Neurol"},{"issue":"1","key":"2463_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1167\/iovs.13-12888","volume":"55","author":"Y Tsai","year":"2014","unstructured":"Tsai Y, Lu B, Ljubimov AV, Girman S, Ross-Cisneros FN, Sadun AA, Svendsen CN, Cohen RM, Wang S (2014) Ocular changes in TgF344-AD rat model of Alzheimer\u2019s disease. Investig Ophthalmol Vis Sci 55(1):523\u2013534. doi: 10.1167\/iovs.13-12888","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"2463_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","volume":"132","author":"NJ Hart","year":"2016","unstructured":"Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indicators of Alzheimer\u2019s: exploring disease in the retina. Acta Neuropathol (Berl) 132(6):767\u2013787. doi: 10.1007\/s00401-016-1613-6","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"2463_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362(4):329\u2013344. doi: 10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"issue":"5580","key":"2463_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. doi: 10.1126\/science.1072994","journal-title":"Science"},{"key":"2463_CR16","doi-asserted-by":"publisher","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 7(3):280\u2013292. doi: 10.1016\/j.jalz.2011.03.003","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"2463_CR17","doi-asserted-by":"publisher","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2(5):a006270. doi: 10.1101\/cshperspect.a006270","DOI":"10.1101\/cshperspect.a006270"},{"issue":"26","key":"2463_CR18","doi-asserted-by":"crossref","first-page":"17741","DOI":"10.1016\/S0021-9258(17)32503-6","volume":"269","author":"C Haass","year":"1994","unstructured":"Haass C, Hung AY, Selkoe DJ, Teplow DB (1994) Mutations associated with a locus for familial Alzheimer\u2019s disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 269(26):17741\u201317748","journal-title":"J Biol Chem"},{"key":"2463_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0074-7750(08)00004-9","volume":"36","author":"WB Zigman","year":"2008","unstructured":"Zigman WB, Devenny DA, Krinsky-McHale SJ, Jenkins EC, Urv TK, Wegiel J, Schupf N, Silverman W (2008) Alzheimer\u2019s disease in adults with down syndrome. Int Rev Res Ment Retard 36:103\u2013145. doi: 10.1016\/s0074-7750(08)00004-9","journal-title":"Int Rev Res Ment Retard"},{"issue":"5","key":"2463_CR20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS (1996) Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1-42\/1\u201340 ratio in vitro and in vivo. Neuron 17(5):1005\u20131013","journal-title":"Neuron"},{"issue":"1","key":"2463_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77(1):43\u201351. doi: 10.1016\/j.biopsych.2014.05.006","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2463_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/ejhg.2015.173","volume":"24","author":"G Nicolas","year":"2016","unstructured":"Nicolas G, Wallon D, Charbonnier C, Quenez O, Rousseau S, Richard AC, Rovelet-Lecrux A, Coutant S, Le Guennec K, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Munter HM, Bourque G, Auld D, Montpetit A, Lathrop M, Guyant-Marechal L, Martinaud O, Pariente J, Rollin-Sillaire A, Pasquier F, Le Ber I, Sarazin M, Croisile B, Boutoleau-Bretonniere C, Thomas-Anterion C, Paquet C, Sauvee M, Moreaud O, Gabelle A, Sellal F, Ceccaldi M, Chamard L, Blanc F, Frebourg T, Campion D, Hannequin D (2016) Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons. Eur J Hum Genet 24(5):710\u2013716. doi: 10.1038\/ejhg.2015.173","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"2463_CR23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2(8):864\u2013870","journal-title":"Nat Med"},{"issue":"7409","key":"2463_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jonsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488(7409):96\u201399. doi: 10.1038\/nature11283","journal-title":"Nature"},{"issue":"45","key":"2463_CR25","doi-asserted-by":"publisher","first-page":"30977","DOI":"10.1074\/jbc.M114.599027","volume":"289","author":"I Benilova","year":"2014","unstructured":"Benilova I, Gallardo R, Ungureanu AA, Castillo Cano V, Snellinx A, Ramakers M, Bartic C, Rousseau F, Schymkowitz J, De Strooper B (2014) The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-beta (Abeta) aggregation. J Biol Chem 289(45):30977\u201330989. doi: 10.1074\/jbc.M114.599027","journal-title":"J Biol Chem"},{"issue":"2","key":"2463_CR26","doi-asserted-by":"publisher","first-page":"e31039","DOI":"10.1371\/journal.pone.0031039","volume":"7","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, St Jean P, Lawson M, Ehm MG, Mayeux R, Goate AM (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PloS one 7(2):e31039. doi: 10.1371\/journal.pone.0031039","journal-title":"PloS one"},{"key":"2463_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl203","author":"K Sleegers","year":"2006","unstructured":"Sleegers K, Brouwers N, Gijselinck I, Theuns J, Goossens D, Wauters J, Del-Favero J, Cruts M, van Duijn CM, Van Broeckhoven C (2006) APP duplication is sufficient to cause early onset Alzheimer\u2019s dementia with cerebral amyloid angiopathy. Brain J Neurol 129(Pt 11):2977\u20132983. doi: 10.1093\/brain\/awl203","journal-title":"Brain J Neurol"},{"issue":"3","key":"2463_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","volume":"33","author":"RJ Guerreiro","year":"2012","unstructured":"Guerreiro RJ, Gustafson DR, Hardy J (2012) The genetic architecture of Alzheimer\u2019s disease: beyond APP, PSENs and APOE. Neurobiol Aging 33(3):437\u2013456. doi: 10.1016\/j.neurobiolaging.2010.03.025","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2463_CR29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00001756-199602290-00029","volume":"7","author":"M Hutton","year":"1996","unstructured":"Hutton M, Busfield F, Wragg M, Crook R, Perez-Tur J, Clark RF, Prihar G, Talbot C, Phillips H, Wright K, Baker M, Lendon C, Duff K, Martinez A, Houlden H, Nichols A, Karran E, Roberts G, Roques P, Rossor M, Venter JC, Adams MD, Cline RT, Phillips CA, Goate A et al (1996) Complete analysis of the presenilin 1 gene in early onset Alzheimer\u2019s disease. Neuroreport 7(3):801\u2013805","journal-title":"Neuroreport"},{"key":"2463_CR30","doi-asserted-by":"crossref","unstructured":"Barton AJ, Crook BW, Karran EH, Brown F, Dewar D, Mann DM, Pearson RC, Graham DI, Hardy J, Hutton M, Duff K, Goate AM, Clark RF, Roberts GW (1996) Alteration in brain presenilin 1 mRNA expression in early onset familial Alzheimer\u2019s disease. Neurodegeneration 5(3):213\u2013218","DOI":"10.1006\/neur.1996.0029"},{"key":"2463_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/b978-0-12-800149-3.00005-6","volume":"87","author":"V Chouraki","year":"2014","unstructured":"Chouraki V, Seshadri S (2014) Genetics of Alzheimer\u2019s disease. Adv Genet 87:245\u2013294. doi: 10.1016\/b978-0-12-800149-3.00005-6","journal-title":"Adv Genet"},{"key":"2463_CR32","doi-asserted-by":"publisher","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Moron FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fievet N, Huentelman MW, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuiness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossu P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Deniz Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F, Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannefelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O\u2019Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH, Jr., Bennett DA, Harris TB, Fratiglioni L, Holmes C, de Bruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltuenen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nature genetics 45(12):1452\u20131458. doi: 10.1038\/ng.2802","DOI":"10.1038\/ng.2802"},{"issue":"5","key":"2463_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O\u2019Donovan M, Amouyel P, Williams J (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43(5):429\u2013435. doi: 10.1038\/ng.803","journal-title":"Nat Genet"},{"issue":"5","key":"2463_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43(5):436\u2013441. doi: 10.1038\/ng.801","journal-title":"Nat Genet"},{"issue":"2","key":"2463_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1471-4159.2008.05433.x","volume":"106","author":"SL Chan","year":"2008","unstructured":"Chan SL, Kim WS, Kwok JB, Hill AF, Cappai R, Rye KA, Garner B (2008) ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem 106(2):793\u2013804. doi: 10.1111\/j.1471-4159.2008.05433.x","journal-title":"J Neurochem"},{"issue":"10","key":"2463_CR36","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1523\/jneurosci.4165-12.2013","volume":"33","author":"WS Kim","year":"2013","unstructured":"Kim WS, Li H, Ruberu K, Chan S, Elliott DA, Low JK, Cheng D, Karl T, Garner B (2013) Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer\u2019s disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 33(10):4387\u20134394. doi: 10.1523\/jneurosci.4165-12.2013","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"9","key":"2463_CR37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamaneurol.2013.2815","volume":"70","author":"JM Shulman","year":"2013","unstructured":"Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA (2013) Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol 70(9):1150\u20131157. doi: 10.1001\/jamaneurol.2013.2815","journal-title":"JAMA Neurol"},{"issue":"40","key":"2463_CR38","doi-asserted-by":"publisher","first-page":"24152","DOI":"10.1074\/jbc.M115.655076","volume":"290","author":"K Satoh","year":"2015","unstructured":"Satoh K, Abe-Dohmae S, Yokoyama S, St George-Hyslop P, Fraser PE (2015) ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing. J Biol Chem 290(40):24152\u201324165. doi: 10.1074\/jbc.M115.655076","journal-title":"J Biol Chem"},{"issue":"2","key":"2463_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/jad-160456","volume":"54","author":"Y Fu","year":"2016","unstructured":"Fu Y, Hsiao JH, Paxinos G, Halliday GM, Kim WS (2016) ABCA7 Mediates Phagocytic Clearance of Amyloid-beta in the. Brain J Alzheimer\u2019s Dis JAD 54(2):569\u2013584. doi: 10.3233\/jad-160456","journal-title":"Brain J Alzheimer\u2019s Dis JAD"},{"issue":"17","key":"2463_CR40","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/emboj.2010.167","volume":"29","author":"PH Kuhn","year":"2010","unstructured":"Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. Embo j 29(17):3020\u20133032. doi: 10.1038\/emboj.2010.167","journal-title":"Embo j"},{"issue":"5","key":"2463_CR41","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1046\/j.1471-4159.2000.0752133.x","volume":"75","author":"M Marcinkiewicz","year":"2000","unstructured":"Marcinkiewicz M, Seidah NG (2000) Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J Neurochem 75(5):2133\u20132143","journal-title":"J Neurochem"},{"issue":"2","key":"2463_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","volume":"80","author":"J Suh","year":"2013","unstructured":"Suh J, Choi SH, Romano DM, Gannon MA, Lesinski AN, Kim DY, Tanzi RE (2013) ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function. Neuron 80(2):385\u2013401. doi: 10.1016\/j.neuron.2013.08.035","journal-title":"Neuron"},{"issue":"20","key":"2463_CR43","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","volume":"18","author":"M Kim","year":"2009","unstructured":"Kim M, Suh J, Romano D, Truong MH, Mullin K, Hooli B, Norton D, Tesco G, Elliott K, Wagner SL, Moir RD, Becker KD, Tanzi RE (2009) Potential late-onset Alzheimer\u2019s disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum Mol Genet 18(20):3987\u20133996. doi: 10.1093\/hmg\/ddp323","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2463_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/alzrt257","volume":"6","author":"HM Jochemsen","year":"2014","unstructured":"Jochemsen HM, Teunissen CE, Ashby EL, van der Flier WM, Jones RE, Geerlings MI, Scheltens P, Kehoe PG, Muller M (2014) The association of angiotensin-converting enzyme with biomarkers for Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 6(3):27. doi: 10.1186\/alzrt257","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"2463_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/5009","volume":"21","author":"PG Kehoe","year":"1999","unstructured":"Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 21(1):71\u201372. doi: 10.1038\/5009","journal-title":"Nat Genet"},{"issue":"1","key":"2463_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1):17\u201323. doi: 10.1038\/ng1934","journal-title":"Nat Genet"},{"issue":"4","key":"2463_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/aje\/kwi202","volume":"162","author":"DJ Lehmann","year":"2005","unstructured":"Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, van Duijn CM, Kehoe PG (2005) Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer\u2019s disease. Am J Epidemiol 162(4):305\u2013317. doi: 10.1093\/aje\/kwi202","journal-title":"Am J Epidemiol"},{"key":"2463_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12929","author":"PS Chou","year":"2016","unstructured":"Chou PS, Wu MN, Chou MC, Chien I, Yang YH (2016) Angiotensin-converting enzyme insertion\/deletion polymorphism and the longitudinal progression of Alzheimer\u2019s disease. Geriatr Gerontol Int. doi: 10.1111\/ggi.12929","journal-title":"Geriatr Gerontol Int"},{"issue":"10","key":"2463_CR49","doi-asserted-by":"publisher","first-page":"e1004758","DOI":"10.1371\/journal.pgen.1004758","volume":"10","author":"JS Kauwe","year":"2014","unstructured":"Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holtzman DM, Morris JC, Goate AM (2014) Genome-wide association study of CSF levels of 59 alzheimer\u2019s disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. PLoS Genet 10(10):e1004758. doi: 10.1371\/journal.pgen.1004758","journal-title":"PLoS Genet"},{"issue":"5","key":"2463_CR50","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajmg.b.30899","volume":"150b","author":"TL Edwards","year":"2009","unstructured":"Edwards TL, Pericak-Vance M, Gilbert JR, Haines JL, Martin ER, Ritchie MD (2009) An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet Part B Neuropsychiatr Genet 150b(5):721\u2013735. doi: 10.1002\/ajmg.b.30899","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"issue":"5123","key":"2463_CR51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261(5123):921\u2013923","journal-title":"Science"},{"issue":"89","key":"2463_CR52","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Goate AM, Bales KR, Paul SM, Bateman RJ, Holtzman DM (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3(89):89ra57. doi: 10.1126\/scitranslmed.3002156","journal-title":"Sci Transl Med"},{"issue":"12","key":"2463_CR53","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/jci36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118(12):4002\u20134013. doi: 10.1172\/jci36663","journal-title":"J Clin Invest"},{"issue":"19","key":"2463_CR54","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions. Proc Natl Acad Sci USA 110(19):E1807\u2013E1816. doi: 10.1073\/pnas.1220484110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"2463_CR55","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM (1999) Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 96(26):15233\u201315238","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2463_CR56","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/mp.2013.194","volume":"19","author":"C Conejero-Goldberg","year":"2014","unstructured":"Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, Chen S, Davies P, Goldberg TE (2014) APOE2 enhances neuroprotection against Alzheimer\u2019s disease through multiple molecular mechanisms. Mol Psychiatry 19(11):1243\u20131250. doi: 10.1038\/mp.2013.194","journal-title":"Mol Psychiatry"},{"issue":"9","key":"2463_CR57","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Kamboh MI, Kofler JK, Mash DC, Duque L, Gilbert JR, Gwirtsman H, Buxbaum JD, Kramer P, Dickson DW, Farrer LA, Frosch MP, Ghetti B, Haines JL, Hyman BT, Kukull WA, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Reiman EM, Schellenberg GD, Montine TJ (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias. PLoS Genet 10(9):e1004606. doi: 10.1371\/journal.pgen.1004606","journal-title":"PLoS Genet"},{"issue":"1","key":"2463_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12017-015-8376-4","volume":"18","author":"M Rezazadeh","year":"2016","unstructured":"Rezazadeh M, Khorrami A, Yeghaneh T, Talebi M, Kiani SJ, Heshmati Y, Gharesouran J (2016) Genetic factors affecting late-onset alzheimer\u2019s disease susceptibility. Neuromol Med 18(1):37\u201349. doi: 10.1007\/s12017-015-8376-4","journal-title":"Neuromol Med"},{"key":"2463_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw146","author":"T Miyagawa","year":"2016","unstructured":"Miyagawa T, Ebinuma I, Morohashi Y, Hori Y, Young Chang M, Hattori H, Maehara T, Yokoshima S, Fukuyama T, Tsuji S, Iwatsubo T, Prendergast GC, Tomita T (2016) BIN1 regulates BACE1 intracellular trafficking and amyloid-beta production. Hum Mol Genet. doi: 10.1093\/hmg\/ddw146","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2463_CR60","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, Zommer N, Hamdane M, Bellenguez C, Dartigues JF, Hauw JJ, Letronne F, Ayral AM, Sleegers K, Schellens A, Broeck LV, Engelborghs S, De Deyn PP, Vandenberghe R, O\u2019Donovan M, Owen M, Epelbaum J, Mercken M, Karran E, Bantscheff M, Drewes G, Joberty G, Campion D, Octave JN, Berr C, Lathrop M, Callaerts P, Mann D, Williams J, Buee L, Dewachter I, Van Broeckhoven C, Amouyel P, Moechars D, Dermaut B, Lambert JC (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18(11):1225\u20131234. doi: 10.1038\/mp.2013.1","journal-title":"Mol Psychiatry"},{"issue":"10","key":"2463_CR61","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","volume":"19","author":"MS Tan","year":"2013","unstructured":"Tan MS, Yu JT, Tan L (2013) Bridging integrator 1 (BIN1): form, function, and Alzheimer\u2019s disease. Trends Mol Med 19(10):594\u2013603. doi: 10.1016\/j.molmed.2013.06.004","journal-title":"Trends Mol Med"},{"issue":"2","key":"2463_CR62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0854.2003.40205.x","volume":"4","author":"M Cormont","year":"2003","unstructured":"Cormont M, Meton I, Mari M, Monzo P, Keslair F, Gaskin C, McGraw TE, Le Marchand-Brustel Y (2003) CD2AP\/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl. Traffic 4(2):97\u2013112","journal-title":"Traffic"},{"key":"2463_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13024-015-0006-y","volume":"10","author":"F Liao","year":"2015","unstructured":"Liao F, Jiang H, Srivatsan S, Xiao Q, Lefton KB, Yamada K, Mahan TE, Lee JM, Shaw AS, Holtzman DM (2015) Effects of CD2-associated protein deficiency on amyloid-beta in neuroblastoma cells and in an APP transgenic mouse model. Mol Neurodegener 10:12. doi: 10.1186\/s13024-015-0006-y","journal-title":"Mol Neurodegener"},{"issue":"7","key":"2463_CR64","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A, Morris MC, Evans DA, Johnson K, Sperling RA, Schneider JA, Bennett DA, De Jager PL (2013) CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16(7):848\u2013850. doi: 10.1038\/nn.3435","journal-title":"Nat Neurosci"},{"issue":"4","key":"2463_CR65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE (2013) Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78(4):631\u2013643. doi: 10.1016\/j.neuron.2013.04.014","journal-title":"Neuron"},{"key":"2463_CR66","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2015.10.007","volume":"609","author":"YF Mao","year":"2015","unstructured":"Mao YF, Guo ZY, Pu JL, Chen YX, Zhang BR (2015) Association of CD33 and MS4A cluster variants with Alzheimer\u2019s disease in East Asian populations. Neurosci Lett 609:235\u2013239. doi: 10.1016\/j.neulet.2015.10.007","journal-title":"Neurosci Lett"},{"issue":"5","key":"2463_CR67","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I, Jiang H, Laird N, Moscarillo T, Ohlsen KL, Elliott K, Wang X, Hu-Lince D, Ryder M, Murphy A, Wagner SL, Blacker D, Becker KD, Tanzi RE (2008) Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet 83(5):623\u2013632. doi: 10.1016\/j.ajhg.2008.10.008","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2463_CR68","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27(5):909\u2013918. doi: 10.1038\/sj.jcbfm.9600419","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2463_CR69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1995.1080","volume":"136","author":"T Oda","year":"1995","unstructured":"Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF et al (1995) Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1\u201342) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol 136(1):22\u201331","journal-title":"Exp Neurol"},{"issue":"13","key":"2463_CR70","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1074\/jbc.270.13.7563","volume":"270","author":"E Matsubara","year":"1995","unstructured":"Matsubara E, Frangione B, Ghiso J (1995) Characterization of apolipoprotein J-Alzheimer\u2019s A beta interaction. J Biol Chem 270(13):7563\u20137567","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"2463_CR71","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/bj3160671","volume":"316","author":"E Matsubara","year":"1996","unstructured":"Matsubara E, Soto C, Governale S, Frangione B, Ghiso J (1996) Apolipoprotein J and Alzheimer\u2019s amyloid beta solubility. Biochem J 316(Pt 2):671\u2013679","journal-title":"Biochem J"},{"issue":"10","key":"2463_CR72","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J Off Publ Feder Am Soc Exp Biol 21 (10):2312\u20132322. doi: 10.1096\/fj.06-7986com","journal-title":"FASEB J Off Publ Feder Am Soc Exp Biol"},{"issue":"3","key":"2463_CR73","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuint.2006.11.002","volume":"50","author":"T Nuutinen","year":"2007","unstructured":"Nuutinen T, Huuskonen J, Suuronen T, Ojala J, Miettinen R, Salminen A (2007) Amyloid-beta 1\u201342 induced endocytosis and clusterin\/apoJ protein accumulation in cultured human astrocytes. Neurochem Int 50(3):540\u2013547. doi: 10.1016\/j.neuint.2006.11.002","journal-title":"Neurochem Int"},{"issue":"2","key":"2463_CR74","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","volume":"61","author":"T Nuutinen","year":"2009","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A (2009) Clusterin: a forgotten player in Alzheimer\u2019s disease. Brain Res Rev 61(2):89\u2013104. doi: 10.1016\/j.brainresrev.2009.05.007","journal-title":"Brain Res Rev"},{"issue":"2","key":"2463_CR75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M, May PC, O\u2019Dell MA, Taylor JW, Harmony JA, Aronow BJ, Bales KR, Paul SM, Holtzman DM (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41(2):193\u2013202","journal-title":"Neuron"},{"issue":"10","key":"2463_CR76","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41(10):1094\u20131099. doi: 10.1038\/ng.439","journal-title":"Nat Genet"},{"issue":"11","key":"2463_CR77","doi-asserted-by":"publisher","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM (2012) Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PloS one 7(11):e50976. doi: 10.1371\/journal.pone.0050976","journal-title":"PloS one"},{"key":"2463_CR78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nbd.2013.02.003","volume":"54","author":"H Crehan","year":"2013","unstructured":"Crehan H, Hardy J, Pocock J (2013) Blockage of CR1 prevents activation of rodent microglia. Neurobiol Dis 54:139\u2013149. doi: 10.1016\/j.nbd.2013.02.003","journal-title":"Neurobiol Dis"},{"key":"2463_CR79","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/cia.s105769","volume":"11","author":"M Giri","year":"2016","unstructured":"Giri M, Zhang M, Lu Y (2016) Genes associated with Alzheimer\u2019s disease: an overview and current status. Clinical interventions in aging 11:665\u2013681. doi: 10.2147\/cia.s105769","journal-title":"Clinical interventions in aging"},{"issue":"3","key":"2463_CR80","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-012-0996-2","volume":"124","author":"GD Schellenberg","year":"2012","unstructured":"Schellenberg GD, Montine TJ (2012) The genetics and neuropathology of Alzheimer\u2019s disease. Acta Neuropathol (Berl) 124(3):305\u2013323. doi: 10.1007\/s00401-012-0996-2","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"2463_CR81","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/147323001103900220","volume":"39","author":"A Sakamoto","year":"2011","unstructured":"Sakamoto A, Sugamoto Y, Tokunaga Y, Yoshimuta T, Hayashi K, Konno T, Kawashiri MA, Takeda Y, Yamagishi M (2011) Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells. J Int Med Res 39(2):522\u2013527","journal-title":"J Int Med Res"},{"issue":"3","key":"2463_CR82","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.conb.2009.04.009","volume":"19","author":"KO Lai","year":"2009","unstructured":"Lai KO, Ip NY (2009) Synapse development and plasticity: roles of ephrin\/Eph receptor signaling. Curr Opin Neurobiol 19(3):275\u2013283. doi: 10.1016\/j.conb.2009.04.009","journal-title":"Curr Opin Neurobiol"},{"issue":"10","key":"2463_CR83","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, Heun R, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O\u2019Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41(10):1088\u20131093. doi: 10.1038\/ng.440","journal-title":"Nat Genet"},{"issue":"5","key":"2463_CR84","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cell.2011.10.038","volume":"147","author":"SE Miller","year":"2011","unstructured":"Miller SE, Sahlender DA, Graham SC, Honing S, Robinson MS, Peden AA, Owen DJ (2011) The molecular basis for the endocytosis of small R-SNAREs by the clathrin adaptor CALM. Cell 147(5):1118\u20131131. doi: 10.1016\/j.cell.2011.10.038","journal-title":"Cell"},{"issue":"2","key":"2463_CR85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.devcel.2015.03.002","volume":"33","author":"SE Miller","year":"2015","unstructured":"Miller SE, Mathiasen S, Bright NA, Pierre F, Kelly BT, Kladt N, Schauss A, Merrifield CJ, Stamou D, Honing S, Owen DJ (2015) CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature. Dev Cell 33(2):163\u2013175. doi: 10.1016\/j.devcel.2015.03.002","journal-title":"Dev Cell"},{"issue":"25","key":"2463_CR86","doi-asserted-by":"publisher","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","volume":"287","author":"Q Xiao","year":"2012","unstructured":"Xiao Q, Gil SC, Yan P, Wang Y, Han S, Gonzales E, Perez R, Cirrito JR, Lee JM (2012) Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem 287(25):21279\u201321289. doi: 10.1074\/jbc.M111.338376","journal-title":"J Biol Chem"},{"key":"2463_CR87","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1038\/ncomms4386","volume":"5","author":"K Kanatsu","year":"2014","unstructured":"Kanatsu K, Morohashi Y, Suzuki M, Kuroda H, Watanabe T, Tomita T, Iwatsubo T (2014) Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin-mediated endocytosis of gamma-secretase. Nature communications 5:3386. doi: 10.1038\/ncomms4386","journal-title":"Nature communications"},{"issue":"42","key":"2463_CR88","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1073\/pnas.1315110110","volume":"110","author":"Y Tian","year":"2013","unstructured":"Tian Y, Chang JC, Fan EY, Flajolet M, Greengard P (2013) Adaptor complex AP2\/PICALM, through interaction with LC3, targets Alzheimer\u2019s APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci USA 110(42):17071\u201317076. doi: 10.1073\/pnas.1315110110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2463_CR89","doi-asserted-by":"publisher","first-page":"e91242","DOI":"10.1371\/journal.pone.0091242","volume":"9","author":"I Parikh","year":"2014","unstructured":"Parikh I, Fardo DW, Estus S (2014) Genetics of PICALM expression and Alzheimer\u2019s disease. PloS One 9(3):e91242. doi: 10.1371\/journal.pone.0091242","journal-title":"PloS One"},{"issue":"48","key":"2463_CR90","doi-asserted-by":"publisher","first-page":"40364","DOI":"10.1074\/jbc.M509329200","volume":"280","author":"J Chen","year":"2005","unstructured":"Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280(48):40364\u201340374. doi: 10.1074\/jbc.M509329200","journal-title":"J Biol Chem"},{"issue":"31","key":"2463_CR91","doi-asserted-by":"publisher","first-page":"21745","DOI":"10.1074\/jbc.M602909200","volume":"281","author":"W Qin","year":"2006","unstructured":"Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745\u201321754. doi: 10.1074\/jbc.M602909200","journal-title":"J Biol Chem"},{"key":"2463_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-016-2110-y","author":"H Jesko","year":"2016","unstructured":"Jesko H, Wencel P, Strosznajder RP, Strosznajder JB (2016) Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem Res. doi: 10.1007\/s11064-016-2110-y","journal-title":"Neurochem Res"},{"key":"2463_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0087-9","author":"R Corpas","year":"2016","unstructured":"Corpas R, Revilla S, Ursulet S, Castro-Freire M, Kaliman P, Petegnief V, Gimenez-Llort L, Sarkis C, Pallas M, Sanfeliu C (2016) SIRT1 overexpression in mouse hippocampus induces cognitive enhancement through proteostatic and neurotrophic mechanisms. Mol Neurobiol. doi: 10.1007\/s12035-016-0087-9","journal-title":"Mol Neurobiol"},{"issue":"9","key":"2463_CR94","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1007\/s12035-015-9546-y","volume":"53","author":"Z Wang","year":"2016","unstructured":"Wang Z, Lei H, Zheng M, Li Y, Cui Y, Hao F (2016) Meta-analysis of the association between Alzheimer disease and variants in GAB2, PICALM, and SORL1. Mol Neurobiol 53(9):6501\u20136510. doi: 10.1007\/s12035-015-9546-y","journal-title":"Mol Neurobiol"},{"key":"2463_CR95","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2013.11.042","volume":"559","author":"X Xue","year":"2014","unstructured":"Xue X, Zhang M, Lin Y, Xu E, Jia J (2014) Association between the SORL1 rs2070045 polymorphism and late-onset Alzheimer\u2019s disease: interaction with the ApoE genotype in the Chinese Han population. Neurosci Lett 559:94\u201398. doi: 10.1016\/j.neulet.2013.11.042","journal-title":"Neurosci Lett"},{"issue":"2","key":"2463_CR96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116. doi: 10.1056\/NEJMoa1211103","journal-title":"N Engl J Med"},{"issue":"14","key":"2463_CR97","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1091\/mbc.E12-01-0014","volume":"23","author":"JH Herskowitz","year":"2012","unstructured":"Herskowitz JH, Offe K, Deshpande A, Kahn RA, Levey AI, Lah JJ (2012) GGA1-mediated endocytic traffic of LR11\/SorLA alters APP intracellular distribution and amyloid-beta production. Mol Biol Cell 23(14):2645\u20132657. doi: 10.1091\/mbc.E12-01-0014","journal-title":"Mol Biol Cell"},{"issue":"4","key":"2463_CR98","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1523\/jneurosci.2272-11.2012","volume":"32","author":"AW Fjorback","year":"2012","unstructured":"Fjorback AW, Seaman M, Gustafsen C, Mehmedbasic A, Gokool S, Wu C, Militz D, Schmidt V, Madsen P, Nyengaard JR, Willnow TE, Christensen EI, Mobley WB, Nykjaer A, Andersen OM (2012) Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J Neurosci Off J Soc Neurosci 32(4):1467\u20131480. doi: 10.1523\/jneurosci.2272-11.2012","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"1","key":"2463_CR99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/emboj.2011.352","volume":"31","author":"V Schmidt","year":"2012","unstructured":"Schmidt V, Baum K, Lao A, Rateitschak K, Schmitz Y, Teichmann A, Wiesner B, Petersen CM, Nykjaer A, Wolf J, Wolkenhauer O, Willnow TE (2012) Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer\u2019s disease. Embo j 31(1):187\u2013200. doi: 10.1038\/emboj.2011.352","journal-title":"Embo j"},{"issue":"45","key":"2463_CR100","doi-asserted-by":"publisher","first-page":"32956","DOI":"10.1074\/jbc.M705073200","volume":"282","author":"V Schmidt","year":"2007","unstructured":"Schmidt V, Sporbert A, Rohe M, Reimer T, Rehm A, Andersen OM, Willnow TE (2007) SorLA\/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 282(45):32956\u201332964. doi: 10.1074\/jbc.M705073200","journal-title":"J Biol Chem"},{"issue":"6","key":"2463_CR101","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ana.21190","volume":"62","author":"KL Sager","year":"2007","unstructured":"Sager KL, Wuu J, Leurgans SE, Rees HD, Gearing M, Mufson EJ, Levey AI, Lah JJ (2007) Neuronal LR11\/sorLA expression is reduced in mild cognitive impairment. Ann Neurol 62(6):640\u2013647. doi: 10.1002\/ana.21190","journal-title":"Ann Neurol"},{"issue":"10","key":"2463_CR102","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jalz.2014.10.013","volume":"11","author":"P Roussos","year":"2015","unstructured":"Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V (2015) The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer\u2019s dementia. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 11(10):1163\u20131170. doi: 10.1016\/j.jalz.2014.10.013","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"4","key":"2463_CR103","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1371\/journal.pmed.0040124","volume":"4","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4(4):e124. doi: 10.1371\/journal.pmed.0040124","journal-title":"PLoS Med"},{"issue":"4","key":"2463_CR104","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201(4):647\u2013657. doi: 10.1084\/jem.20041611","journal-title":"J Exp Med"},{"issue":"4","key":"2463_CR105","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","volume":"109","author":"CL Hsieh","year":"2009","unstructured":"Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109(4):1144\u20131156. doi: 10.1111\/j.1471-4159.2009.06042.x","journal-title":"J Neurochem"},{"key":"2463_CR106","doi-asserted-by":"crossref","unstructured":"Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. Journal of immunology (Baltimore, Md : 1950) 177 (4):2051\u20132055","DOI":"10.4049\/jimmunol.177.4.2051"},{"key":"2463_CR107","doi-asserted-by":"crossref","unstructured":"Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M (2006) Cutting edge: TREM-2 attenuates macrophage activation. Journal of immunology (Baltimore, Md : 1950) 177 (6):3520\u20133524","DOI":"10.4049\/jimmunol.177.6.3520"},{"issue":"1","key":"2463_CR108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/jad-122311","volume":"35","author":"C Pottier","year":"2013","unstructured":"Pottier C, Wallon D, Rousseau S, Rovelet-Lecrux A, Richard AC, Rollin-Sillaire A, Frebourg T, Campion D, Hannequin D (2013) TREM2 R47H variant as a risk factor for early-onset Alzheimer\u2019s disease. Journal of Alzheimer\u2019s disease : JAD 35(1):45\u201349. doi: 10.3233\/jad-122311","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"issue":"189","key":"2463_CR109","doi-asserted-by":"publisher","first-page":"189ra177","DOI":"10.1126\/scitranslmed.3005615","volume":"5","author":"R Potter","year":"2013","unstructured":"Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, Yarasheski KE, Holtzman DM, Morris JC, Benzinger TL, Bateman RJ (2013) Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med 5(189):189ra177. doi: 10.1126\/scitranslmed.3005615","journal-title":"Sci Transl Med"},{"issue":"6012","key":"2463_CR110","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330(6012):1774. doi: 10.1126\/science.1197623","journal-title":"Science"},{"issue":"5618","key":"2463_CR111","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300(5618):486\u2013489. doi: 10.1126\/science.1079469","journal-title":"Science"},{"key":"2463_CR112","doi-asserted-by":"publisher","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nature reviews Molecular cell biology 8 (2):101\u2013112. doi: 10.1038\/nrm2101","DOI":"10.1038\/nrm2101"},{"issue":"7082","key":"2463_CR113","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesn\u00e9","year":"2006","unstructured":"Lesn\u00e9 S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352\u2013357. doi: 10.1038\/nature04533","journal-title":"Nature"},{"issue":"6","key":"2463_CR114","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46(6):860\u2013866","journal-title":"Ann Neurol"},{"key":"2463_CR115","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq065","author":"JM Mc Donald","year":"2010","unstructured":"Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, Selkoe DJ, Ince PG, Walsh DM (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain : a journal of neurology 133 (Pt 5):1328\u20131341. doi: 10.1093\/brain\/awq065","journal-title":"Brain : a journal of neurology"},{"issue":"6880","key":"2463_CR116","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880):535\u2013539. doi: 10.1038\/416535a","journal-title":"Nature"},{"issue":"1","key":"2463_CR117","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8(1):79\u201384. doi: 10.1038\/nn1372","journal-title":"Nat Neurosci"},{"issue":"8","key":"2463_CR118","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14(8):837\u2013842. doi: 10.1038\/nm1782","journal-title":"Nat Med"},{"issue":"2","key":"2463_CR119","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol (Berl) 129(2):183\u2013206. doi: 10.1007\/s00401-015-1386-3","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"2463_CR120","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","volume":"17","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997) Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. The Journal of neuroscience : the official journal of the Society for Neuroscience 17(3):1046\u20131054","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"2463_CR121","doi-asserted-by":"publisher","unstructured":"Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease. FASEB J 19 (14):2040\u20132041. doi: 10.1096\/fj.05-3735fje","DOI":"10.1096\/fj.05-3735fje"},{"issue":"9","key":"2463_CR122","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","volume":"15","author":"M Manczak","year":"2006","unstructured":"Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer\u2019s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15(9):1437\u20131449. doi: 10.1093\/hmg\/ddl066","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2463_CR123","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405. doi: 10.1016\/s1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"4","key":"2463_CR124","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","volume":"88","author":"KI Mosher","year":"2014","unstructured":"Mosher KI, Wyss-Coray T (2014) Microglial dysfunction in brain aging and Alzheimer\u2019s disease. Biochem Pharmacol 88(4):594\u2013604. doi: 10.1016\/j.bcp.2014.01.008","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2463_CR125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2005-7304","volume":"7","author":"M Fiala","year":"2005","unstructured":"Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J, Sofroni E, Suarez T, Chiappelli F, Bernard G (2005) Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer\u2019s disease patients. Journal of Alzheimer\u2019s disease : JAD 7(3):221\u2013232 discussion 255\u2013262","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"issue":"7","key":"2463_CR126","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF03401753","volume":"4","author":"M Fiala","year":"1998","unstructured":"Fiala M, Zhang L, Gan X, Sherry B, Taub D, Graves MC, Hama S, Way D, Weinand M, Witte M, Lorton D, Kuo YM, Roher AE (1998) Amyloid-beta induces chemokine secretion and monocyte migration across a human blood\u2013brain barrier model. Mol Med 4(7):480\u2013489","journal-title":"Mol Med"},{"issue":"2","key":"2463_CR127","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3233\/jad-131160","volume":"38","author":"M Saresella","year":"2014","unstructured":"Saresella M, Marventano I, Calabrese E, Piancone F, Rainone V, Gatti A, Alberoni M, Nemni R, Clerici M (2014) A complex proinflammatory role for peripheral monocytes in Alzheimer\u2019s disease. JAD 38(2):403\u2013413. doi: 10.3233\/jad-131160","journal-title":"JAD"},{"issue":"6587","key":"2463_CR128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/382120b0","volume":"382","author":"MA Smith","year":"1996","unstructured":"Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer\u2019s. Nature 382(6587):120\u2013121. doi: 10.1038\/382120b0","journal-title":"Nature"},{"issue":"1","key":"2463_CR129","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol (Berl) 118(1):103\u2013113. doi: 10.1007\/s00401-009-0522-3","journal-title":"Acta Neuropathol (Berl)"},{"key":"2463_CR130","doi-asserted-by":"publisher","unstructured":"Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, Group AT (2016) Alzheimer`s disease and the early signs of age-related macular degeneration. Curr Alzheimer Res 13(11):1259\u20131266. doi: 10.2174\/1567205013666160603003800","DOI":"10.2174\/1567205013666160603003800"},{"key":"2463_CR131","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv327","author":"IF Kimbrough","year":"2015","unstructured":"Kimbrough IF, Robel S, Roberson ED, Sontheimer H (2015) Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer\u2019s disease. Brain J Neurol 138(Pt 12):3716\u20133733. doi: 10.1093\/brain\/awv327","journal-title":"Brain J Neurol"},{"issue":"3","key":"2463_CR132","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61(3):378\u2013384. doi: 10.1001\/archneur.61.3.378","journal-title":"Arch Neurol"},{"key":"2463_CR133","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv050","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR, Dickson DW (2015) Clinicopathologic and 11\u00a0C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain J Neurol 138(Pt 5):1370\u20131381. doi: 10.1093\/brain\/awv050","journal-title":"Brain J Neurol"},{"issue":"2","key":"2463_CR134","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ana.24188","volume":"76","author":"E Karran","year":"2014","unstructured":"Karran E, Hardy J (2014) A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol 76(2):185\u2013205. doi: 10.1002\/ana.24188","journal-title":"Ann Neurol"},{"key":"2463_CR135","doi-asserted-by":"publisher","unstructured":"Morris GP, Clark IA, Vissel B (2014) Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease. Acta Neuropathol Commun 2:135. doi: 10.1186\/s40478-014-0135-5","DOI":"10.1186\/s40478-014-0135-5"},{"issue":"1","key":"2463_CR136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/jad-2010-101638","volume":"24","author":"M Chen","year":"2011","unstructured":"Chen M, Maleski JJ, Sawmiller DR (2011) Scientific truth or false hope? Understanding Alzheimer\u2019s disease from an aging perspective. JAD 24(1):3\u201310. doi: 10.3233\/jad-2010-101638","journal-title":"JAD"},{"issue":"50","key":"2463_CR137","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1523\/jneurosci.4521-10.2010","volume":"30","author":"K Herrup","year":"2010","unstructured":"Herrup K (2010) Reimagining Alzheimer\u2019s disease\u2014an age-based hypothesis. J Neurosci 30(50):16755\u201316762. doi: 10.1523\/jneurosci.4521-10.2010","journal-title":"J Neurosci"},{"key":"2463_CR138","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nlm.2013.07.002","volume":"105","author":"GP Morris","year":"2013","unstructured":"Morris GP, Clark IA, Zinn R, Vissel B (2013) Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research. Neurobiol Learn Mem 105:40\u201353. doi: 10.1016\/j.nlm.2013.07.002","journal-title":"Neurobiol Learn Mem"},{"key":"2463_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.08.018","author":"R Kandimalla","year":"2016","unstructured":"Kandimalla R, Thirumala V, Reddy PH (2016) Is Alzheimer\u2019s disease a Type 3 diabetes? A critical appraisal. Biochim Biophys Acta. doi: 10.1016\/j.bbadis.2016.08.018","journal-title":"Biochim Biophys Acta"},{"issue":"5534","key":"2463_CR140","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293(5534):1491\u20131495. doi: 10.1126\/science.1062097","journal-title":"Science"},{"issue":"5534","key":"2463_CR141","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487\u20131491. doi: 10.1126\/science.1058189","journal-title":"Science"},{"issue":"14","key":"2463_CR142","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci USA 108(14):5819\u20135824. doi: 10.1073\/pnas.1017033108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7526","key":"2463_CR143","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D\u2019Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, Woolf CJ, Wagner SL, Tanzi RE, Kim DY (2014) A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515(7526):274\u2013278. doi: 10.1038\/nature13800","journal-title":"Nature"},{"key":"2463_CR144","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv150","author":"Y Koronyo","year":"2015","unstructured":"Koronyo Y, Salumbides BC, Sheyn J, Pelissier L, Li S, Ljubimov V, Moyseyev M, Daley D, Fuchs DT, Pham M, Black KL, Rentsendorj A, Koronyo-Hamaoui M (2015) Therapeutic effects of glatiramer acetate and grafted CD115(+) monocytes in a mouse model of Alzheimer\u2019s disease. Brain J Neurol 138(Pt 8):2399\u20132422. doi: 10.1093\/brain\/awv150","journal-title":"Brain J Neurol"},{"issue":"3","key":"2463_CR145","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1172\/JCI66541","volume":"124","author":"KE Bernstein","year":"2014","unstructured":"Bernstein KE, Koronyo Y, Salumbides BC, Sheyn J, Pelissier L, Lopes DH, Shah KH, Bernstein EA, Fuchs DT, Yu JJ, Pham M, Black KL, Shen XZ, Fuchs S, Koronyo-Hamaoui M (2014) Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer\u2019s-like cognitive decline. J Clin Invest 124(3):1000\u20131012. doi: 10.1172\/JCI66541","journal-title":"J Clin Invest"},{"issue":"29","key":"2463_CR146","doi-asserted-by":"publisher","first-page":"9651","DOI":"10.1523\/jneurosci.0329-10.2010","volume":"30","author":"L Lebson","year":"2010","unstructured":"Lebson L, Nash K, Kamath S, Herber D, Carty N, Lee DC, Li Q, Szekeres K, Jinwal U, Koren J, Dickey CA, Gottschall PE, Morgan D, Gordon MN (2010) Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. J Neurosci 30(29):9651\u20139658. doi: 10.1523\/jneurosci.0329-10.2010","journal-title":"J Neurosci"},{"issue":"7618","key":"2463_CR147","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O\u2019Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (2016) The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease. Nature 537(7618):50\u201356. doi: 10.1038\/nature19323","journal-title":"Nature"},{"issue":"6","key":"2463_CR148","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1471-4159.2009.06402.x","volume":"111","author":"M Koronyo-Hamaoui","year":"2009","unstructured":"Koronyo-Hamaoui M, Ko MK, Koronyo Y, Azoulay D, Seksenyan A, Kunis G, Pham M, Bakhsheshian J, Rogeri P, Black KL, Farkas DL, Schwartz M (2009) Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J Neurochem 111(6):1409\u20131424. doi: 10.1111\/j.1471-4159.2009.06402.x","journal-title":"J Neurochem"},{"key":"2463_CR149","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000002922","author":"EC Mormino","year":"2016","unstructured":"Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR (2016) Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology. doi: 10.1212\/wnl.0000000000002922","journal-title":"Neurology"},{"issue":"3","key":"2463_CR150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-2002-4308","volume":"4","author":"WB Grant","year":"2002","unstructured":"Grant WB, Campbell A, Itzhaki RF, Savory J (2002) The significance of environmental factors in the etiology of Alzheimer\u2019s disease. JAD 4(3):179\u2013189","journal-title":"JAD"},{"issue":"16","key":"2463_CR151","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples L, Haines JL et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease: a meta-analysis. JAMA 278(16):1349\u20131356. doi: 10.1001\/jama.1997.03550160069041","journal-title":"JAMA"},{"issue":"53","key":"2463_CR152","doi-asserted-by":"publisher","first-page":"44593","DOI":"10.1074\/jbc.M112.420224","volume":"287","author":"J Li","year":"2012","unstructured":"Li J, Kanekiyo T, Shinohara M, Zhang Y, LaDu MJ, Xu H, Bu G (2012) Differential regulation of amyloid-beta endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J Biol Chem 287(53):44593\u201344601. doi: 10.1074\/jbc.M112.420224","journal-title":"J Biol Chem"},{"issue":"7399","key":"2463_CR153","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485(7399):512\u2013516. doi: 10.1038\/nature11087","journal-title":"Nature"},{"issue":"4","key":"2463_CR154","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jnc.13072","volume":"133","author":"LM Tai","year":"2015","unstructured":"Tai LM, Ghura S, Koster KP, Liakaite V, Maienschein-Cline M, Kanabar P, Collins N, Ben-Aissa M, Lei AZ, Bahroos N, Green SJ, Hendrickson B, Van Eldik LJ, LaDu MJ (2015) APOE-modulated Abeta-induced neuroinflammation in Alzheimer\u2019s disease: current landscape, novel data, and future perspective. J Neurochem 133(4):465\u2013488. doi: 10.1111\/jnc.13072","journal-title":"J Neurochem"},{"issue":"2","key":"2463_CR155","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127. doi: 10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"key":"2463_CR156","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-015-0048-1","volume":"10","author":"M Malik","year":"2015","unstructured":"Malik M, Parikh I, Vasquez JB, Smith C, Tai L, Bu G, LaDu MJ, Fardo DW, Rebeck GW, Estus S (2015) Genetics ignite focus on microglial inflammation in Alzheimer\u2019s disease. Mol Neurodegener 10:52. doi: 10.1186\/s13024-015-0048-1","journal-title":"Mol Neurodegener"},{"issue":"15","key":"2463_CR157","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1212\/wnl.0000000000000855","volume":"83","author":"BV Hooli","year":"2014","unstructured":"Hooli BV, Parrado AR, Mullin K, Yip WK, Liu T, Roehr JT, Qiao D, Jessen F, Peters O, Becker T, Ramirez A, Lange C, Bertram L, Tanzi RE (2014) The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Neurology 83(15):1353\u20131358. doi: 10.1212\/wnl.0000000000000855","journal-title":"Neurology"},{"issue":"9","key":"2463_CR158","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1484","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12(9):1005\u20131015. doi: 10.1038\/nm1484","journal-title":"Nat Med"},{"issue":"12","key":"2463_CR159","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/jci10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106(12):1489\u20131499. doi: 10.1172\/jci10498","journal-title":"J Clin Invest"},{"issue":"2","key":"2463_CR160","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","volume":"18","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. Brain Pathol 18(2):253\u2013266. doi: 10.1111\/j.1750-3639.2008.00133.x","journal-title":"Brain Pathol"},{"key":"2463_CR161","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.112.678698","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Nedergaard M (2013) Is there a cerebral lymphatic system? Stroke 44(6 Suppl 1):S93\u201395. doi: 10.1161\/strokeaha.112.678698","journal-title":"Stroke"},{"issue":"147","key":"2463_CR162","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra111. doi: 10.1126\/scitranslmed.3003748","journal-title":"Sci Transl Med"},{"issue":"8","key":"2463_CR163","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/glia.20973","volume":"58","author":"T Malm","year":"2010","unstructured":"Malm T, Koistinaho M, Muona A, Magga J, Koistinaho J (2010) The role and therapeutic potential of monocytic cells in Alzheimer\u2019s disease. Glia 58(8):889\u2013900. doi: 10.1002\/glia.20973","journal-title":"Glia"},{"issue":"45","key":"2463_CR164","doi-asserted-by":"publisher","first-page":"37644","DOI":"10.1074\/jbc.M508460200","volume":"280","author":"ML Hemming","year":"2005","unstructured":"Hemming ML, Selkoe DJ (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280(45):37644\u201337650. doi: 10.1074\/jbc.M508460200","journal-title":"J Biol Chem"},{"issue":"23","key":"2463_CR165","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1523\/JNEUROSCI.20-23-08745.2000","volume":"20","author":"A Mukherjee","year":"2000","unstructured":"Mukherjee A, Song E, Kihiko-Ehmann M, Goodman JP Jr, Pyrek JS, Estus S, Hersh LB (2000) Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci 20(23):8745\u20138749","journal-title":"J Neurosci"},{"issue":"2","key":"2463_CR166","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(03)00898-X","volume":"350","author":"H Kanemitsu","year":"2003","unstructured":"Kanemitsu H, Tomiyama T, Mori H (2003) Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350(2):113\u2013116","journal-title":"Neurosci Lett"},{"issue":"43","key":"2463_CR167","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1523\/jneurosci.2085-06.2006","volume":"26","author":"KJ Yin","year":"2006","unstructured":"Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26(43):10939\u201310948. doi: 10.1523\/jneurosci.2085-06.2006","journal-title":"J Neurosci"},{"issue":"3","key":"2463_CR168","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jnr.10390","volume":"70","author":"N Iwata","year":"2002","unstructured":"Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC (2002) Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J Neurosci Res 70(3):493\u2013500. doi: 10.1002\/jnr.10390","journal-title":"J Neurosci Res"},{"issue":"1","key":"2463_CR169","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-0102(02)00015-9","volume":"43","author":"S Fukami","year":"2002","unstructured":"Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, Gerard C, Fraser P, Westaway D, St George-Hyslop P, Saido TC (2002) Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res 43(1):39\u201356","journal-title":"Neurosci Res"},{"issue":"33","key":"2463_CR170","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/jneurosci.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci 28(33):8354\u20138360. doi: 10.1523\/jneurosci.0616-08.2008","journal-title":"J Neurosci"},{"issue":"10","key":"2463_CR171","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s11064-007-9349-2","volume":"32","author":"L Fisk","year":"2007","unstructured":"Fisk L, Nalivaeva NN, Boyle JP, Peers CS, Turner AJ (2007) Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res 32(10):1741\u20131748. doi: 10.1007\/s11064-007-9349-2","journal-title":"Neurochem Res"},{"issue":"5","key":"2463_CR172","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.2353\/ajpath.2008.070620","volume":"172","author":"SS El-Amouri","year":"2008","unstructured":"El-Amouri SS, Zhu H, Yu J, Marr R, Verma IM, Kindy MS (2008) Neprilysin: an enzyme candidate to slow the progression of Alzheimer\u2019s disease. Am J Pathol 172(5):1342\u20131354. doi: 10.2353\/ajpath.2008.070620","journal-title":"Am J Pathol"},{"key":"2463_CR173","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.exer.2015.06.027","volume":"138","author":"R Parthasarathy","year":"2015","unstructured":"Parthasarathy R, Chow KM, Derafshi Z, Fautsch MP, Hetling JR, Rodgers DW, Hersh LB, Pepperberg DR (2015) Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin. Exp Eye Res 138:134\u2013144. doi: 10.1016\/j.exer.2015.06.027","journal-title":"Exp Eye Res"},{"key":"2463_CR174","doi-asserted-by":"crossref","unstructured":"Kurochkin IV, Goto S (1994) Alzheimer\u2019s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345 (1):33\u201337","DOI":"10.1016\/0014-5793(94)00387-4"},{"issue":"49","key":"2463_CR175","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273(49):32730\u201332738","journal-title":"J Biol Chem"},{"issue":"1","key":"2463_CR176","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/jad-2010-1206","volume":"19","author":"A Bulloj","year":"2010","unstructured":"Bulloj A, Leal MC, Xu H, Castano EM, Morelli L (2010) Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease. JAD 19(1):79\u201395. doi: 10.3233\/jad-2010-1206","journal-title":"JAD"},{"issue":"5","key":"2463_CR177","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","volume":"20","author":"K Vekrellis","year":"2000","unstructured":"Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ (2000) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20(5):1657\u20131665","journal-title":"J Neurosci"},{"issue":"1","key":"2463_CR178","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-4547(19990101)55:1<44::AID-JNR6>3.0.CO;2-G","volume":"55","author":"S Deb","year":"1999","unstructured":"Deb S, Zhang JW, Gottschall PE (1999) Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to beta-amyloid peptide. J Neurosci Res 55(1):44\u201353","journal-title":"J Neurosci Res"},{"key":"2463_CR179","doi-asserted-by":"publisher","unstructured":"Fujioka H, Dairyo Y, Yasunaga K, Emoto K (2012) Neural functions of matrix metalloproteinases: plasticity, neurogenesis, and disease. Biochem Res Int 2012:789083. doi: 10.1155\/2012\/789083","DOI":"10.1155\/2012\/789083"},{"issue":"2","key":"2463_CR180","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/jad-142460","volume":"46","author":"B Terni","year":"2015","unstructured":"Terni B, Ferrer I (2015) Abnormal expression and distribution of MMP2 at initial stages of Alzheimer\u2019s disease-related pathology. JAD 46(2):461\u2013469. doi: 10.3233\/jad-142460","journal-title":"JAD"},{"key":"2463_CR181","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2011.02.078","volume":"1387","author":"W Li","year":"2011","unstructured":"Li W, Poteet E, Xie L, Liu R, Wen Y, Yang SH (2011) Regulation of matrix metalloproteinase 2 by oligomeric amyloid beta protein. Brain Res 1387:141\u2013148. doi: 10.1016\/j.brainres.2011.02.078","journal-title":"Brain Res"},{"issue":"3","key":"2463_CR182","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1006\/bbrc.1994.2872","volume":"205","author":"AE Roher","year":"1994","unstructured":"Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, Fridman R (1994) Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Commun 205(3):1755\u20131761. doi: 10.1006\/bbrc.1994.2872","journal-title":"Biochem Biophys Res Commun"},{"issue":"26","key":"2463_CR183","doi-asserted-by":"publisher","first-page":"17670","DOI":"10.1074\/jbc.M602487200","volume":"281","author":"AR White","year":"2006","unstructured":"White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, Masters CL (2006) Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281(26):17670\u201317680. doi: 10.1074\/jbc.M602487200","journal-title":"J Biol Chem"},{"issue":"6","key":"2463_CR184","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.exger.2006.11.012","volume":"42","author":"S Ito","year":"2007","unstructured":"Ito S, Kimura K, Haneda M, Ishida Y, Sawada M, Isobe K (2007) Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K\/Akt pathway. Exp Gerontol 42(6):532\u2013537. doi: 10.1016\/j.exger.2006.11.012","journal-title":"Exp Gerontol"},{"issue":"11","key":"2463_CR185","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1523\/jneurosci.5302-08.2009","volume":"29","author":"L Zhao","year":"2009","unstructured":"Zhao L, Lin S, Bales KR, Gelfanova V, Koger D, Delong C, Hale J, Liu F, Hunter JM, Paul SM (2009) Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J Neurosci 29(11):3603\u20133612. doi: 10.1523\/jneurosci.5302-08.2009","journal-title":"J Neurosci"},{"issue":"34","key":"2463_CR186","doi-asserted-by":"publisher","first-page":"24566","DOI":"10.1074\/jbc.M602440200","volume":"281","author":"P Yan","year":"2006","unstructured":"Yan P, Hu X, Song H, Yin K, Bateman RJ, Cirrito JR, Xiao Q, Hsu FF, Turk JW, Xu J, Hsu CY, Holtzman DM, Lee JM (2006) Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem 281(34):24566\u201324574. doi: 10.1074\/jbc.M602440200","journal-title":"J Biol Chem"},{"key":"2463_CR187","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnagi.2015.00047","volume":"7","author":"C Humpel","year":"2015","unstructured":"Humpel C (2015) Organotypic vibrosections from whole brain adult Alzheimer mice (overexpressing amyloid-precursor-protein with the Swedish-Dutch-Iowa mutations) as a model to study clearance of beta-amyloid plaques. Front Aging Neurosci 7:47. doi: 10.3389\/fnagi.2015.00047","journal-title":"Front Aging Neurosci"},{"issue":"24","key":"2463_CR188","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1523\/JNEUROSCI.16-24-07910.1996","volume":"16","author":"JR Backstrom","year":"1996","unstructured":"Backstrom JR, Lim GP, Cullen MJ, Tokes ZA (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1\u201340). J Neurosci 16(24):7910\u20137919","journal-title":"J Neurosci"},{"issue":"3","key":"2463_CR189","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/jnr.490420307","volume":"42","author":"PE Gottschall","year":"1995","unstructured":"Gottschall PE, Yu X, Bing B (1995) Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 42(3):335\u2013342. doi: 10.1002\/jnr.490420307","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"2463_CR190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-328X(02)00132-8","volume":"100","author":"EM Muir","year":"2002","unstructured":"Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH (2002) Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100(1\u20132):103\u2013117","journal-title":"Brain Res Mol Brain Res"},{"issue":"7","key":"2463_CR191","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s11906-014-0444-x","volume":"16","author":"M Koronyo-Hamaoui","year":"2014","unstructured":"Koronyo-Hamaoui M, Shah K, Koronyo Y, Bernstein E, Giani JF, Janjulia T, Black KL, Shi PD, Gonzalez-Villalobos RA, Fuchs S, Shen XZ, Bernstein KE (2014) ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer\u2019s disease. Curr Hypertens Rep 16(7):444. doi: 10.1007\/s11906-014-0444-x","journal-title":"Curr Hypertens Rep"},{"issue":"46","key":"2463_CR192","doi-asserted-by":"publisher","first-page":"31914","DOI":"10.1074\/jbc.M109.011437","volume":"284","author":"K Zou","year":"2009","unstructured":"Zou K, Maeda T, Watanabe A, Liu J, Liu S, Oba R, Satoh Y, Komano H, Michikawa M (2009) Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. J Biol Chem 284(46):31914\u201331920. doi: 10.1074\/jbc.M109.011437","journal-title":"J Biol Chem"},{"issue":"3","key":"2463_CR193","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/01.RES.83.3.314","volume":"83","author":"FD Russell","year":"1998","unstructured":"Russell FD, Skepper JN, Davenport AP (1998) Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83(3):314\u2013321","journal-title":"Circ Res"},{"issue":"9","key":"2463_CR194","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/mt.2008.148","volume":"16","author":"NC Carty","year":"2008","unstructured":"Carty NC, Nash K, Lee D, Mercer M, Gottschall PE, Meyers C, Muzyczka N, Gordon MN, Morgan D (2008) Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol Ther 16(9):1580\u20131586. doi: 10.1038\/mt.2008.148","journal-title":"Mol Ther"},{"issue":"27","key":"2463_CR195","doi-asserted-by":"publisher","first-page":"24540","DOI":"10.1074\/jbc.M007579200","volume":"276","author":"EA Eckman","year":"2001","unstructured":"Eckman EA, Reed DK, Eckman CB (2001) Degradation of the Alzheimer\u2019s amyloid beta peptide by endothelin-converting enzyme. J Biol Chem 276(27):24540\u201324548. doi: 10.1074\/jbc.M007579200","journal-title":"J Biol Chem"},{"issue":"1","key":"2463_CR196","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/jad-131370","volume":"41","author":"G Hook","year":"2014","unstructured":"Hook G, Yu J, Toneff T, Kindy M, Hook V (2014) Brain pyroglutamate amyloid-beta is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer\u2019s disease therapeutic. Journal of Alzheimer\u2019s disease : JAD 41(1):129\u2013149. doi: 10.3233\/jad-131370","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"issue":"8","key":"2463_CR197","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/bc.2010.110","volume":"391","author":"V Hook","year":"2010","unstructured":"Hook V, Hook G, Kindy M (2010) Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer\u2019s disease. Biol Chem 391(8):861\u2013872. doi: 10.1515\/bc.2010.110","journal-title":"Biol Chem"},{"issue":"2","key":"2463_CR198","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbrc.2009.05.131","volume":"386","author":"VY Hook","year":"2009","unstructured":"Hook VY, Kindy M, Reinheckel T, Peters C, Hook G (2009) Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun 386(2):284\u2013288. doi: 10.1016\/j.bbrc.2009.05.131","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2463_CR199","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","volume":"51","author":"S Mueller-Steiner","year":"2006","unstructured":"Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L (2006) Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer\u2019s disease. Neuron 51(6):703\u2013714. doi: 10.1016\/j.neuron.2006.07.027","journal-title":"Neuron"},{"issue":"10","key":"2463_CR200","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1073\/pnas.87.10.3861","volume":"87","author":"AM Cataldo","year":"1990","unstructured":"Cataldo AM, Nixon RA (1990) Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 87(10):3861\u20133865","journal-title":"Proc Natl Acad Sci USA"},{"issue":"47","key":"2463_CR201","doi-asserted-by":"publisher","first-page":"39834","DOI":"10.1074\/jbc.M112.371641","volume":"287","author":"C Wang","year":"2012","unstructured":"Wang C, Sun B, Zhou Y, Grubb A, Gan L (2012) Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein. J Biol Chem 287(47):39834\u201339841. doi: 10.1074\/jbc.M112.371641","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"2463_CR202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0014-5793(96)01087-3","volume":"396","author":"H Hamazaki","year":"1996","unstructured":"Hamazaki H (1996) Cathepsin D is involved in the clearance of Alzheimer\u2019s beta-amyloid protein. FEBS Lett 396 (2\u20133):139\u2013142","journal-title":"FEBS Lett"},{"issue":"50","key":"2463_CR203","doi-asserted-by":"crossref","first-page":"31885","DOI":"10.1074\/jbc.271.50.31885","volume":"271","author":"J Higaki","year":"1996","unstructured":"Higaki J, Catalano R, Guzzetta AW, Quon D, Nave JF, Tarnus C, D\u2019Orchymont H, Cordell B (1996) Processing of beta-amyloid precursor protein by cathepsin D. J Biol Chem 271(50):31885\u201331893","journal-title":"J Biol Chem"},{"issue":"28","key":"2463_CR204","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1016\/S0021-9258(17)32325-6","volume":"269","author":"US Ladror","year":"1994","unstructured":"Ladror US, Snyder SW, Wang GT, Holzman TF, Krafft GA (1994) Cleavage at the amino and carboxyl termini of Alzheimer\u2019s amyloid-beta by cathepsin D. J Biol Chem 269(28):18422\u201318428","journal-title":"J Biol Chem"},{"issue":"12","key":"2463_CR205","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tins.2009.07.006","volume":"32","author":"PG Kehoe","year":"2009","unstructured":"Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimer\u2019s disease\u2014friend or foe? Trends Neurosci 32(12):619\u2013628. doi: 10.1016\/j.tins.2009.07.006","journal-title":"Trends Neurosci"},{"issue":"2","key":"2463_CR206","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","volume":"34","author":"JS Miners","year":"2008","unstructured":"Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S, Kehoe PG (2008) Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer\u2019s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 34(2):181\u2013193. doi: 10.1111\/j.1365-2990.2007.00885.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"2463_CR207","first-page":"163","volume":"1","author":"S Miners","year":"2009","unstructured":"Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, Prince JA, Love S, Kehoe PG (2009) Angiotensin-converting enzyme levels and activity in Alzheimer\u2019s disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res 1(2):163\u2013177","journal-title":"Am J Transl Res"},{"issue":"10","key":"2463_CR208","doi-asserted-by":"publisher","first-page":"e111406","DOI":"10.1371\/journal.pone.0111406","volume":"9","author":"XB Wang","year":"2014","unstructured":"Wang XB, Cui NH, Yang J, Qiu XP, Gao JJ, Yang N, Zheng F (2014) Angiotensin-converting enzyme insertion\/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis. PloS One 9(10):e111406. doi: 10.1371\/journal.pone.0111406","journal-title":"PloS One"},{"issue":"32","key":"2463_CR209","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1523\/jneurosci.1549-07.2007","volume":"27","author":"K Zou","year":"2007","unstructured":"Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, Mizoguchi K, Gong JS, Yu W, Yamamoto T, Kosaka K, Yanagisawa K, Michikawa M (2007) Angiotensin-converting enzyme converts amyloid beta-protein 1\u201342 (Abeta(1\u201342)) to Abeta(1\u201340), and its inhibition enhances brain Abeta deposition. J Neurosci 27(32):8628\u20138635. doi: 10.1523\/jneurosci.1549-07.2007","journal-title":"J Neurosci"},{"issue":"10","key":"2463_CR210","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1073\/pnas.1031520100","volume":"100","author":"BC Miller","year":"2003","unstructured":"Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100(10):6221\u20136226. doi: 10.1073\/pnas.1031520100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2463_CR211","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","volume":"26","author":"A Caccamo","year":"2005","unstructured":"Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM (2005) Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol Aging 26(5):645\u2013654. doi: 10.1016\/j.neurobiolaging.2004.06.013","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2463_CR212","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/NEN.0b013e3181afe475","volume":"68","author":"JS Miners","year":"2009","unstructured":"Miners JS, Baig S, Tayler H, Kehoe PG, Love S (2009) Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol 68(8):902\u2013914. doi: 10.1097\/NEN.0b013e3181afe475","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"2463_CR213","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1750-3639.2010.00375.x","volume":"20","author":"JS Miners","year":"2010","unstructured":"Miners JS, van Helmond Z, Kehoe PG, Love S (2010) Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol 20(4):794\u2013802. doi: 10.1111\/j.1750-3639.2010.00375.x","journal-title":"Brain Pathol"},{"issue":"1","key":"2463_CR214","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","volume":"162","author":"DG Cook","year":"2003","unstructured":"Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S (2003) Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 162(1):313\u2013319","journal-title":"Am J Pathol"},{"key":"2463_CR215","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2014.06.021","volume":"70","author":"A Fragkouli","year":"2014","unstructured":"Fragkouli A, Tsilibary EC, Tzinia AK (2014) Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer\u2019s 5xFAD mice. Neurobiol Dis 70:179\u2013189. doi: 10.1016\/j.nbd.2014.06.021","journal-title":"Neurobiol Dis"},{"issue":"26","key":"2463_CR216","doi-asserted-by":"publisher","first-page":"23511","DOI":"10.1074\/jbc.M009466200","volume":"276","author":"YH Chong","year":"2001","unstructured":"Chong YH, Sung JH, Shin SA, Chung JH, Suh YH (2001) Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer\u2019s amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J Biol Chem 276(26):23511\u201323517. doi: 10.1074\/jbc.M009466200","journal-title":"J Biol Chem"},{"issue":"5","key":"2463_CR217","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4062\/biomolther.2014.099","volume":"22","author":"EJ Lee","year":"2014","unstructured":"Lee EJ, Moon PG, Baek MC, Kim HS (2014) Comparison of the effects of matrix metalloproteinase inhibitors on TNF-alpha release from activated microglia and TNF-alpha converting enzyme activity. Biomol Ther (Seoul) 22 (5):414\u2013419. doi: 10.4062\/biomolther.2014.099","journal-title":"Biomol Ther (Seoul)"},{"issue":"7","key":"2463_CR218","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","volume":"2","author":"VW Yong","year":"2001","unstructured":"Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2(7):502\u2013511. doi: 10.1038\/35081571","journal-title":"Nat Rev Neurosci"},{"issue":"16","key":"2463_CR219","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1097\/00001756-200011090-00029","volume":"11","author":"RC Castro de Jr","year":"2000","unstructured":"de Castro RC Jr, Burns CL, McAdoo DJ, Romanic AM (2000) Metalloproteinase increases in the injured rat spinal cord. Neuroreport 11(16):3551\u20133554","journal-title":"Neuroreport"},{"issue":"24","key":"2463_CR220","doi-asserted-by":"publisher","first-page":"21895","DOI":"10.1074\/jbc.M008511200","volume":"276","author":"K Shirotani","year":"2001","unstructured":"Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC (2001) Neprilysin degrades both amyloid beta peptides 1\u201340 and 1\u201342 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276(24):21895\u201321901. doi: 10.1074\/jbc.M008511200","journal-title":"J Biol Chem"},{"issue":"2","key":"2463_CR221","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/72237","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6(2):143\u2013150. doi: 10.1038\/72237","journal-title":"Nat Med"},{"key":"2463_CR222","doi-asserted-by":"publisher","unstructured":"Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A (2005) Neprylisin decreases uniformly in Alzheimer\u2019s disease and in normal aging. FEBS Lett 579 (27):6027\u20136030. doi: 10.1016\/j.febslet.2005.09.054","DOI":"10.1016\/j.febslet.2005.09.054"},{"issue":"5521","key":"2463_CR223","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292(5521):1550\u20131552. doi: 10.1126\/science.1059946","journal-title":"Science"},{"issue":"4","key":"2463_CR224","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3233\/jad-142463","volume":"44","author":"M Huttenrauch","year":"2015","unstructured":"Huttenrauch M, Baches S, Gerth J, Bayer TA, Weggen S, Wirths O (2015) Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer\u2019s disease. JAD 44(4):1291\u20131302. doi: 10.3233\/jad-142463","journal-title":"JAD"},{"issue":"1","key":"2463_CR225","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbr.2005.10.014","volume":"168","author":"A Mouri","year":"2006","unstructured":"Mouri A, Zou LB, Iwata N, Saido TC, Wang D, Wang MW, Noda Y, Nabeshima T (2006) Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory. Behav Brain Res 168(1):83\u201391. doi: 10.1016\/j.bbr.2005.10.014","journal-title":"Behav Brain Res"},{"issue":"9","key":"2463_CR226","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.4049\/jimmunol.181.9.6503","volume":"181","author":"E Shimizu","year":"2008","unstructured":"Shimizu E, Kawahara K, Kajizono M, Sawada M, Nakayama H (2008) IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1\u201342) by rat primary type 2 microglia. J Immunol (Baltimore, Md: 1950) 181 (9):6503\u20136513","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"10","key":"2463_CR227","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1515\/hsz-2013-0295","volume":"395","author":"KE Bernstein","year":"2014","unstructured":"Bernstein KE, Gonzalez-Villalobos RA, Giani JF, Shah K, Bernstein E, Janjulia T, Koronyo Y, Shi PD, Koronyo-Hamaoui M, Fuchs S, Shen XZ (2014) Angiotensin-converting enzyme overexpression in myelocytes enhances the immune response. Biol Chem 395(10):1173\u20131178. doi: 10.1515\/hsz-2013-0295","journal-title":"Biol Chem"},{"issue":"28","key":"2463_CR228","doi-asserted-by":"publisher","first-page":"E3699","DOI":"10.1073\/pnas.1510329112","volume":"112","author":"S Gowrishankar","year":"2015","unstructured":"Gowrishankar S, Yuan P, Wu Y, Schrag M, Paradise S, Grutzendler J, De Camilli P, Ferguson SM (2015) Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer\u2019s disease amyloid plaques. Proc Natl Acad Sci USA 112(28):E3699\u2013E3708. doi: 10.1073\/pnas.1510329112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2463_CR229","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3233\/jad-132192","volume":"42","author":"L Tian","year":"2014","unstructured":"Tian L, Zhang K, Tian ZY, Wang T, Shang DS, Li B, Liu DX, Fang WG, Wang ZY, Chen YH (2014) Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-beta in Alzheimer\u2019s disease. JAD 42(2):511\u2013520. doi: 10.3233\/jad-132192","journal-title":"JAD"},{"issue":"1","key":"2463_CR230","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2011.01.021","volume":"43","author":"RA Nixon","year":"2011","unstructured":"Nixon RA, Yang DS (2011) Autophagy failure in Alzheimer\u2019s disease\u2013locating the primary defect. Neurobiol Dis 43(1):38\u201345. doi: 10.1016\/j.nbd.2011.01.021","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2463_CR231","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","volume":"75","author":"JN Keller","year":"2000","unstructured":"Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer\u2019s disease. J Neurochem 75(1):436\u2013439","journal-title":"J Neurochem"},{"issue":"6","key":"2463_CR232","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3","volume":"52","author":"AJ Yang","year":"1998","unstructured":"Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG (1998) Loss of endosomal\/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 52(6):691\u2013698","journal-title":"J Neurosci Res"},{"issue":"7","key":"2463_CR233","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/jnr.22640","volume":"89","author":"T Umeda","year":"2011","unstructured":"Umeda T, Tomiyama T, Sakama N, Tanaka S, Lambert MP, Klein WL, Mori H (2011) Intraneuronal amyloid beta oligomers cause cell death via endoplasmic reticulum stress, endosomal\/lysosomal leakage, and mitochondrial dysfunction in vivo. J Neurosci Res 89(7):1031\u20131042. doi: 10.1002\/jnr.22640","journal-title":"J Neurosci Res"},{"issue":"5","key":"2463_CR234","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1074\/jbc.M506646200","volume":"281","author":"ZS Ji","year":"2006","unstructured":"Ji ZS, Mullendorff K, Cheng IH, Miranda RD, Huang Y, Mahley RW (2006) Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J Biol Chem 281(5):2683\u20132692. doi: 10.1074\/jbc.M506646200","journal-title":"J Biol Chem"},{"key":"2463_CR235","doi-asserted-by":"crossref","unstructured":"Brunk U, Brun A (1972) The effect of aging on lysosomal permeability in nerve cells of the central nervous system. An enzyme histochemical study in rat. Histochemie 30(4):315\u2013324","DOI":"10.1007\/BF00279780"},{"issue":"24","key":"2463_CR236","doi-asserted-by":"publisher","first-page":"21821","DOI":"10.1074\/jbc.M112109200","volume":"277","author":"ZS Ji","year":"2002","unstructured":"Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW (2002) Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem 277(24):21821\u201321828. doi: 10.1074\/jbc.M112109200","journal-title":"J Biol Chem"},{"issue":"3","key":"2463_CR237","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuroscience.2004.07.036","volume":"129","author":"V Echeverria","year":"2004","unstructured":"Echeverria V, Ducatenzeiler A, Dowd E, Janne J, Grant SM, Szyf M, Wandosell F, Avila J, Grimm H, Dunnett SB, Hartmann T, Alhonen L, Cuello AC (2004) Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 129(3):583\u2013592. doi: 10.1016\/j.neuroscience.2004.07.036","journal-title":"Neuroscience"},{"issue":"12","key":"2463_CR238","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.mad.2005.07.006","volume":"126","author":"S Oh","year":"2005","unstructured":"Oh S, Hong HS, Hwang E, Sim HJ, Lee W, Shin SJ, Mook-Jung I (2005) Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev 126(12):1292\u20131299. doi: 10.1016\/j.mad.2005.07.006","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"2463_CR239","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00227813","volume":"84","author":"J Frackowiak","year":"1992","unstructured":"Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC (1992) Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol (Berl) 84(3):225\u2013233","journal-title":"Acta Neuropathol (Berl)"},{"issue":"46","key":"2463_CR240","doi-asserted-by":"crossref","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","volume":"272","author":"DM Paresce","year":"1997","unstructured":"Paresce DM, Chung H, Maxfield FR (1997) Slow degradation of aggregates of the Alzheimer\u2019s disease amyloid beta-protein by microglial cells. J Biol Chem 272(46):29390\u201329397","journal-title":"J Biol Chem"},{"issue":"5","key":"2463_CR241","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.neurobiolaging.2006.12.001","volume":"29","author":"A Majumdar","year":"2008","unstructured":"Majumdar A, Chung H, Dolios G, Wang R, Asamoah N, Lobel P, Maxfield FR (2008) Degradation of fibrillar forms of Alzheimer\u2019s amyloid beta-peptide by macrophages. Neurobiol Aging 29(5):707\u2013715. doi: 10.1016\/j.neurobiolaging.2006.12.001","journal-title":"Neurobiol Aging"},{"issue":"21","key":"2463_CR242","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","volume":"264","author":"NM Dahms","year":"1989","unstructured":"Dahms NM, Lobel P, Kornfeld S (1989) Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 264(21):12115\u201312118","journal-title":"J Biol Chem"},{"issue":"2","key":"2463_CR243","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neurobiolaging.2013.08.003","volume":"35","author":"R Tiribuzi","year":"2014","unstructured":"Tiribuzi R, Crispoltoni L, Porcellati S, Di Lullo M, Florenzano F, Pirro M, Bagaglia F, Kawarai T, Zampolini M, Orlacchio A, Orlacchio A (2014) miR128 up-regulation correlates with impaired amyloid beta(1\u201342) degradation in monocytes from patients with sporadic Alzheimer\u2019s disease. Neurobiol Aging 35(2):345\u2013356. doi: 10.1016\/j.neurobiolaging.2013.08.003","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2463_CR244","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2010.07.006","volume":"43","author":"H Koga","year":"2011","unstructured":"Koga H, Cuervo AM (2011) Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration. Neurobiol Dis 43(1):29\u201337. doi: 10.1016\/j.nbd.2010.07.006","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2463_CR245","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1515\/revneuro-2014-0076","volume":"26","author":"A Zare-Shahabadi","year":"2015","unstructured":"Zare-Shahabadi A, Masliah E, Johnson GV, Rezaei N (2015) Autophagy in Alzheimer\u2019s disease. Rev Neurosci 26(4):385\u2013395. doi: 10.1515\/revneuro-2014-0076","journal-title":"Rev Neurosci"},{"issue":"2","key":"2463_CR246","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3350217","volume":"335","author":"PE Stromhaug","year":"1998","unstructured":"Stromhaug PE, Berg TO, Fengsrud M, Seglen PO (1998) Purification and characterization of autophagosomes from rat hepatocytes. Biochem J 335(Pt 2):217\u2013224","journal-title":"Biochem J"},{"issue":"5","key":"2463_CR247","doi-asserted-by":"publisher","first-page":"1006.e1011-1023","DOI":"10.1016\/j.neurobiolaging.2011.09.039","volume":"33","author":"SM Son","year":"2012","unstructured":"Son SM, Jung ES, Shin HJ, Byun J, Mook-Jung I (2012) Abeta-induced formation of autophagosomes is mediated by RAGE-CaMKKbeta-AMPK signaling. Neurobiol Aging 33(5):1006.e1011-1023. doi: 10.1016\/j.neurobiolaging.2011.09.039","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2463_CR248","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4161\/auto.27802","volume":"10","author":"Y Tian","year":"2014","unstructured":"Tian Y, Chang JC, Greengard P, Flajolet M (2014) The convergence of endosomal and autophagosomal pathways: implications for APP-CTF degradation. Autophagy 10(4):694\u2013696. doi: 10.4161\/auto.27802","journal-title":"Autophagy"},{"issue":"27","key":"2463_CR249","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/jneurosci.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J Neurosci 28(27):6926\u20136937. doi: 10.1523\/jneurosci.0800-08.2008","journal-title":"J Neurosci"},{"key":"2463_CR250","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.019265","author":"RA Nixon","year":"2007","unstructured":"Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120(Pt 23):4081\u20134091. doi: 10.1242\/jcs.019265","journal-title":"J Cell Sci"},{"key":"2463_CR251","doi-asserted-by":"publisher","unstructured":"Correia SC, Resende R, Moreira PI, Pereira CM (2015) Alzheimer\u2019s disease-related misfolded proteins and dysfunctional organelles on autophagy menu. DNA Cell Biol 34 (4):261\u2013273. doi: 10.1089\/dna.2014.2757","DOI":"10.1089\/dna.2014.2757"},{"issue":"32","key":"2463_CR252","doi-asserted-by":"publisher","first-page":"14164","DOI":"10.1073\/pnas.1009485107","volume":"107","author":"MM Lipinski","year":"2010","unstructured":"Lipinski MM, Zheng B, Lu T, Yan Z, Py BF, Ng A, Xavier RJ, Li C, Yankner BA, Scherzer CR, Yuan J (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 107(32):14164\u201314169. doi: 10.1073\/pnas.1009485107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2463_CR253","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","volume":"5","author":"P Nilsson","year":"2013","unstructured":"Nilsson P, Loganathan K, Sekiguchi M, Matsuba Y, Hui K, Tsubuki S, Tanaka M, Iwata N, Saito T, Saido TC (2013) Abeta secretion and plaque formation depend on autophagy. Cell Rep 5(1):61\u201369. doi: 10.1016\/j.celrep.2013.08.042","journal-title":"Cell Rep"},{"issue":"6","key":"2463_CR254","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1172\/jci33585","volume":"118","author":"F Pickford","year":"2008","unstructured":"Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118(6):2190\u20132199. doi: 10.1172\/jci33585","journal-title":"J Clin Invest"},{"key":"2463_CR255","doi-asserted-by":"publisher","unstructured":"Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584 (7):1287\u20131295. doi: 10.1016\/j.febslet.2010.01.017","DOI":"10.1016\/j.febslet.2010.01.017"},{"issue":"7020","key":"2463_CR256","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature03029","volume":"432","author":"A Kuma","year":"2004","unstructured":"Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N (2004) The role of autophagy during the early neonatal starvation period. Nature 432(7020):1032\u20131036. doi: 10.1038\/nature03029","journal-title":"Nature"},{"issue":"9","key":"2463_CR257","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tcb.2007.07.009","volume":"17","author":"R Scherz-Shouval","year":"2007","unstructured":"Scherz-Shouval R, Elazar Z (2007) ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 17(9):422\u2013427. doi: 10.1016\/j.tcb.2007.07.009","journal-title":"Trends Cell Biol"},{"issue":"16","key":"2463_CR258","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","volume":"272","author":"X Li","year":"2005","unstructured":"Li X, Alafuzoff I, Soininen H, Winblad B, Pei JJ (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer\u2019s disease brain. FEBS J 272(16):4211\u20134220. doi: 10.1111\/j.1742-4658.2005.04833.x","journal-title":"FEBS J"},{"issue":"4","key":"2463_CR259","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. PloS one 5(4):e9979. doi: 10.1371\/journal.pone.0009979","journal-title":"PloS one"},{"issue":"2","key":"2463_CR260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1568-1637(01)00006-X","volume":"1","author":"JN Keller","year":"2002","unstructured":"Keller JN, Gee J, Ding Q (2002) The proteasome in brain aging. Ageing Res Rev 1(2):279\u2013293","journal-title":"Ageing Res Rev"},{"issue":"2","key":"2463_CR261","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/1097-4547(20001015)62:2<302::aid-jnr15>3.0.co;2-l","volume":"62","author":"M Lopez Salon","year":"2000","unstructured":"Lopez Salon M, Morelli L, Castano EM, Soto EF, Pasquini JM (2000) Defective ubiquitination of cerebral proteins in Alzheimer\u2019s disease. J Neurosci Res 62(2):302\u2013310. doi: 10.1002\/1097-4547(20001015)62:2<302::aid-jnr15>3.0.co;2-l","journal-title":"J Neurosci Res"},{"issue":"43","key":"2463_CR262","doi-asserted-by":"publisher","first-page":"32240","DOI":"10.1074\/jbc.M603106200","volume":"281","author":"M Hiltunen","year":"2006","unstructured":"Hiltunen M, Lu A, Thomas AV, Romano DM, Kim M, Jones PB, Xie Z, Kounnas MZ, Wagner SL, Berezovska O, Hyman BT, Tesco G, Bertram L, Tanzi RE (2006) Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion. J Biol Chem 281(43):32240\u201332253. doi: 10.1074\/jbc.M603106200","journal-title":"J Biol Chem"},{"issue":"11","key":"2463_CR263","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","volume":"29","author":"BP Tseng","year":"2008","unstructured":"Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM (2008) Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging 29(11):1607\u20131618. doi: 10.1016\/j.neurobiolaging.2007.04.014","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2463_CR264","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Menard J, Zetterberg H, Wisniewski T, de Leon MJ (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11(8):457\u2013470. doi: 10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2463_CR265","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV (2004) LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43(3):333\u2013344. doi: 10.1016\/j.neuron.2004.07.017","journal-title":"Neuron"},{"key":"2463_CR266","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphys.2013.00045","volume":"4","author":"A Elali","year":"2013","unstructured":"Elali A, Rivest S (2013) The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease. Front Physiol 4:45. doi: 10.3389\/fphys.2013.00045","journal-title":"Front Physiol"},{"issue":"3","key":"2463_CR267","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/jad-2009-1074","volume":"17","author":"LB Jaeger","year":"2009","unstructured":"Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN, Kumar VB, Banks WA (2009) Testing the neurovascular hypothesis of Alzheimer\u2019s disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. JAD 17(3):553\u2013570. doi: 10.3233\/jad-2009-1074","journal-title":"JAD"},{"issue":"10","key":"2463_CR268","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","volume":"69","author":"GD Silverberg","year":"2010","unstructured":"Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, Donahue JE, Johanson CE (2010) Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol 69(10):1034\u20131043. doi: 10.1097\/NEN.0b013e3181f46e25","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"2463_CR269","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10(7):719\u2013726. doi: 10.1038\/nm1058","journal-title":"Nat Med"},{"issue":"2","key":"2463_CR270","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1189\/jlb.1203620","volume":"76","author":"V Laporte","year":"2004","unstructured":"Laporte V, Lombard Y, Levy-Benezra R, Tranchant C, Poindron P, Warter JM (2004) Uptake of Abeta 1-40- and Abeta 1-42-coated yeast by microglial cells: a role for. LRP J Leukocyte Biol 76(2):451\u2013461. doi: 10.1189\/jlb.1203620","journal-title":"LRP J Leukocyte Biol"},{"issue":"49","key":"2463_CR271","doi-asserted-by":"publisher","first-page":"19276","DOI":"10.1523\/jneurosci.3487-13.2013","volume":"33","author":"T Kanekiyo","year":"2013","unstructured":"Kanekiyo T, Cirrito JR, Liu CC, Shinohara M, Li J, Schuler DR, Shinohara M, Holtzman DM, Bu G (2013) Neuronal clearance of amyloid-beta by endocytic receptor LRP1. J Neurosci 33(49):19276\u201319283. doi: 10.1523\/jneurosci.3487-13.2013","journal-title":"J Neurosci"},{"issue":"10","key":"2463_CR272","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/NEN.0b013e3181f52e01","volume":"69","author":"S Baig","year":"2010","unstructured":"Baig S, Joseph SA, Tayler H, Abraham R, Owen MJ, Williams J, Kehoe PG, Love S (2010) Distribution and expression of picalm in Alzheimer disease. J Neuropathol Exp Neurol 69(10):1071\u20131077. doi: 10.1097\/NEN.0b013e3181f52e01","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"2463_CR273","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archneurol.2010.147","volume":"67","author":"MM Carrasquillo","year":"2010","unstructured":"Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG (2010) Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol 67(8):961\u2013964. doi: 10.1001\/archneurol.2010.147","journal-title":"Arch Neurol"},{"issue":"7","key":"2463_CR274","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G, Owens NC, Rege SV, Si G, Ahuja A, Zhu D, Miller CA, Schneider JA, Maeda M, Maeda T, Sugawara T, Ichida JK, Zlokovic BV (2015) Central role for PICALM in amyloid-beta blood-brain barrier transcytosis and clearance. Nat Neurosci 18(7):978\u2013987. doi: 10.1038\/nn.4025","journal-title":"Nat Neurosci"},{"issue":"4852","key":"2463_CR275","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240(4852):622\u2013630","journal-title":"Science"},{"issue":"6238","key":"2463_CR276","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/341162a0","volume":"341","author":"U Beisiegel","year":"1989","unstructured":"Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341(6238):162\u2013164. doi: 10.1038\/341162a0","journal-title":"Nature"},{"issue":"14","key":"2463_CR277","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1074\/jbc.271.14.8373","volume":"271","author":"DH Kim","year":"1996","unstructured":"Kim DH, Iijima H, Goto K, Sakai J, Ishii H, Kim HJ, Suzuki H, Kondo H, Saeki S, Yamamoto T (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem 271(14):8373\u20138380","journal-title":"J Biol Chem"},{"issue":"4","key":"2463_CR278","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G (2014) ApoE and Abeta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron 81(4):740\u2013754. doi: 10.1016\/j.neuron.2014.01.045","journal-title":"Neuron"},{"issue":"5","key":"2463_CR279","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","volume":"25","author":"J Raber","year":"2004","unstructured":"Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25(5):641\u2013650. doi: 10.1016\/j.neurobiolaging.2003.12.023","journal-title":"Neurobiol Aging"},{"issue":"6","key":"2463_CR280","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 97(6):2892\u20132897. doi: 10.1073\/pnas.050004797","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2463_CR281","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90(20):9649\u20139653","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2463_CR282","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977\u20131981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2463_CR283","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-013-1086-9","volume":"125","author":"M Shinohara","year":"2013","unstructured":"Shinohara M, Petersen RC, Dickson DW, Bu G (2013) Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-beta accumulation. Acta Neuropathol (Berl) 125(4):535\u2013547. doi: 10.1007\/s00401-013-1086-9","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"2463_CR284","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/glia.22619","volume":"62","author":"SD Mulder","year":"2014","unstructured":"Mulder SD, Nielsen HM, Blankenstein MA, Eikelenboom P, Veerhuis R (2014) Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro. Glia 62(4):493\u2013503. doi: 10.1002\/glia.22619","journal-title":"Glia"},{"issue":"1","key":"2463_CR285","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 67(1):122\u2013131. doi: 10.1002\/ana.21843","journal-title":"Ann Neurol"},{"issue":"38","key":"2463_CR286","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269(38):23403\u201323406","journal-title":"J Biol Chem"},{"key":"2463_CR287","doi-asserted-by":"publisher","unstructured":"Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE (2013) Evidence for impaired amyloid beta clearance in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 5(4):33. doi: 10.1186\/alzrt187","DOI":"10.1186\/alzrt187"},{"issue":"4","key":"2463_CR288","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","volume":"67","author":"JE Donahue","year":"2008","unstructured":"Donahue JE, Johanson CE (2008) Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease. J Neuropathol Exp Neurol 67(4):261\u2013270. doi: 10.1097\/NEN.0b013e31816a0dc8","journal-title":"J Neuropathol Exp Neurol"},{"issue":"20","key":"2463_CR289","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","volume":"286","author":"K Nishitsuji","year":"2011","unstructured":"Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 286(20):17536\u201317542. doi: 10.1074\/jbc.M111.225532","journal-title":"J Biol Chem"},{"key":"2463_CR290","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1742-2094-11-111","volume":"11","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW (2014) Human APOE4 increases microglia reactivity at Abeta plaques in a mouse model of Abeta deposition. J Neuroinflamm 11:111. doi: 10.1186\/1742-2094-11-111","journal-title":"J Neuroinflamm"},{"issue":"6156","key":"2463_CR291","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O\u2019Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342(6156):373\u2013377. doi: 10.1126\/science.1241224","journal-title":"Science"},{"issue":"7560","key":"2463_CR292","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337\u2013341. doi: 10.1038\/nature14432","journal-title":"Nature"},{"issue":"7","key":"2463_CR293","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212(7):991\u2013999. doi: 10.1084\/jem.20142290","journal-title":"J Exp Med"},{"issue":"6","key":"2463_CR294","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, Xie L, Kang H, Xu Q, Liew JA, Plog BA, Ding F, Deane R, Nedergaard M (2014) Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76(6):845\u2013861. doi: 10.1002\/ana.24271","journal-title":"Ann Neurol"},{"issue":"1","key":"2463_CR295","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nbd.2004.09.009","volume":"18","author":"TM Malm","year":"2005","unstructured":"Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP\/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18(1):134\u2013142. doi: 10.1016\/j.nbd.2004.09.009","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2463_CR296","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","volume":"49","author":"AR Simard","year":"2006","unstructured":"Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease. Neuron 49(4):489\u2013502. doi: 10.1016\/j.neuron.2006.01.022","journal-title":"Neuron"},{"issue":"2","key":"2463_CR297","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1460-9568.2007.05652.x","volume":"26","author":"O Butovsky","year":"2007","unstructured":"Butovsky O, Kunis G, Koronyo-Hamaoui M, Schwartz M (2007) Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer\u2019s disease model. Eur J Neurosci 26(2):413\u2013416. doi: 10.1111\/j.1460-9568.2007.05652.x","journal-title":"Eur J Neurosci"},{"issue":"4","key":"2463_CR298","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J El Khoury","year":"2007","unstructured":"El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13(4):432\u2013438. doi: 10.1038\/nm1555","journal-title":"Nat Med"},{"issue":"3","key":"2463_CR299","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","volume":"17","author":"DM Paresce","year":"1996","unstructured":"Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid beta-protein via a scavenger receptor. Neuron 17(3):553\u2013565","journal-title":"Neuron"},{"issue":"45","key":"2463_CR300","doi-asserted-by":"crossref","first-page":"32301","DOI":"10.1074\/jbc.274.45.32301","volume":"274","author":"H Chung","year":"1999","unstructured":"Chung H, Brazil MI, Soe TT, Maxfield FR (1999) Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer\u2019s amyloid beta-peptide by microglial cells. J Biol Chem 274(45):32301\u201332308","journal-title":"J Biol Chem"},{"issue":"12","key":"2463_CR301","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nm1201-1356","volume":"7","author":"J Priller","year":"2001","unstructured":"Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, Fernandez-Klett F, Prass K, Bechmann I, de Boer BA, Frotscher M, Kreutzberg GW, Persons DA, Dirnagl U (2001) Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med 7(12):1356\u20131361. doi: 10.1038\/nm1201-1356","journal-title":"Nat Med"},{"issue":"16","key":"2463_CR302","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.88.16.7438","volume":"88","author":"JD Sedgwick","year":"1991","unstructured":"Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V (1991) Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88(16):7438\u20137442","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2463_CR303","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.2923","volume":"14","author":"M Prinz","year":"2011","unstructured":"Prinz M, Priller J, Sisodia SS, Ransohoff RM (2011) Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 14(10):1227\u20131235. doi: 10.1038\/nn.2923","journal-title":"Nat Neurosci"},{"issue":"9","key":"2463_CR304","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.4049\/jimmunol.154.9.4309","volume":"154","author":"AL Ford","year":"1995","unstructured":"Ford AL, Goodsall AL, Hickey WF, Sedgwick JD (1995) Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4 + T cells compared. J Immunol (Baltimore, Md: 1950) 154(9):4309\u20134321","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"8","key":"2463_CR305","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.4049\/jimmunol.166.8.5168","volume":"166","author":"AE Juedes","year":"2001","unstructured":"Juedes AE, Ruddle NH (2001) Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol (Baltimore, Md: 1950) 166(8):5168\u20135175","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"1","key":"2463_CR306","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL (2014) Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17(1):131\u2013143. doi: 10.1038\/nn.3599","journal-title":"Nat Neurosci"},{"issue":"5","key":"2463_CR307","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrn3722","volume":"15","author":"M Prinz","year":"2014","unstructured":"Prinz M, Priller J (2014) Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15(5):300\u2013312. doi: 10.1038\/nrn3722","journal-title":"Nat Rev Neurosci"},{"issue":"5966","key":"2463_CR308","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","volume":"327","author":"F Geissmann","year":"2010","unstructured":"Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327(5966):656\u2013661. doi: 10.1126\/science.1178331","journal-title":"Science"},{"issue":"6048","key":"2463_CR309","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048):1456\u20131458. doi: 10.1126\/science.1202529","journal-title":"Science"},{"issue":"11","key":"2463_CR310","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/nn.4142","volume":"18","author":"WS Chung","year":"2015","unstructured":"Chung WS, Welsh CA, Barres BA, Stevens B (2015) Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci 18(11):1539\u20131545. doi: 10.1038\/nn.4142","journal-title":"Nat Neurosci"},{"issue":"5","key":"2463_CR311","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjt028","volume":"5","author":"G Naert","year":"2013","unstructured":"Naert G, Rivest S (2013) A deficiency in CCR2 + monocytes: the hidden side of Alzheimer\u2019s disease. J Mol Cell Biol 5(5):284\u2013293. doi: 10.1093\/jmcb\/mjt028","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"2463_CR312","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.181.6.3877","volume":"181","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto M, Kiyota T, Walsh SM, Liu J, Kipnis J, Ikezu T (2008) Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J Immunol (Baltimore, Md: 1950) 181(6):3877\u20133886","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"2463_CR313","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2014.01.004","volume":"563","author":"N Hu","year":"2014","unstructured":"Hu N, Tan MS, Sun L, Jiang T, Wang YL, Tan L, Zhang W, Yu JT, Tan L (2014) Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer\u2019s disease patients. Neurosci Lett 563:51\u201354. doi: 10.1016\/j.neulet.2014.01.004","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"2463_CR314","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneuroim.2013.01.002","volume":"256","author":"R Zhang","year":"2013","unstructured":"Zhang R, Miller RG, Madison C, Jin X, Honrada R, Harris W, Katz J, Forshew DA, McGrath MS (2013) Systemic immune system alterations in early stages of Alzheimer\u2019s disease. J Neuroimmunol 256(1\u20132):38\u201342. doi: 10.1016\/j.jneuroim.2013.01.002","journal-title":"J Neuroimmunol"},{"issue":"31","key":"2463_CR315","doi-asserted-by":"publisher","first-page":"12849","DOI":"10.1073\/pnas.0701267104","volume":"104","author":"M Fiala","year":"2007","unstructured":"Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, Chiang B, Hui J, Mahanian M, Baghaee A, Hong P, Cashman J (2007) Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer\u2019s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 104(31):12849\u201312854. doi: 10.1073\/pnas.0701267104","journal-title":"Proc Natl Acad Sci USA"},{"key":"2463_CR316","doi-asserted-by":"crossref","unstructured":"Plagg B, Ehrlich D, Kniewallner KM, Marksteiner J, Humpel C (2015) Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic alzheimer\u2019s mice and in human patients. Curr Alzheimer Res 12(8):752\u2013760","DOI":"10.2174\/1567205012666150710114256"},{"issue":"3","key":"2463_CR317","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3233\/jad-2012-111592","volume":"30","author":"K Lunnon","year":"2012","unstructured":"Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A (2012) Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood. JAD 30(3):685\u2013710. doi: 10.3233\/jad-2012-111592","journal-title":"JAD"},{"issue":"48","key":"2463_CR318","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.1523\/jneurosci.2545-05.2005","volume":"25","author":"AK Stalder","year":"2005","unstructured":"Stalder AK, Ermini F, Bondolfi L, Krenger W, Burbach GJ, Deller T, Coomaraswamy J, Staufenbiel M, Landmann R, Jucker M (2005) Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 25(48):11125\u201311132. doi: 10.1523\/jneurosci.2545-05.2005","journal-title":"J Neurosci"},{"issue":"1","key":"2463_CR319","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2353\/ajpath.2010.090840","volume":"177","author":"CD Keene","year":"2010","unstructured":"Keene CD, Chang RC, Lopez-Yglesias AH, Shalloway BR, Sokal I, Li X, Reed PJ, Keene LM, Montine KS, Breyer RM, Rockhill JK, Montine TJ (2010) Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer\u2019s disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow. Am J Pathol 177(1):346\u2013354. doi: 10.2353\/ajpath.2010.090840","journal-title":"Am J Pathol"},{"key":"2463_CR320","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fncel.2012.00051","volume":"6","author":"G Naert","year":"2012","unstructured":"Naert G, Rivest S (2012) Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)\/PS1 mice. Front Cell Neurosci 6:51. doi: 10.3389\/fncel.2012.00051","journal-title":"Front Cell Neurosci"},{"key":"2463_CR321","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn331","author":"V Boissonneault","year":"2009","unstructured":"Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S (2009) Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer\u2019s disease. Brain J Neurol 132(Pt 4):1078\u20131092. doi: 10.1093\/brain\/awn331","journal-title":"Brain J Neurol"},{"issue":"6","key":"2463_CR322","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nm1781","volume":"14","author":"T Town","year":"2008","unstructured":"Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, Duman RS, Flavell RA (2008) Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 14(6):681\u2013687. doi: 10.1038\/nm1781","journal-title":"Nat Med"},{"issue":"13","key":"2463_CR323","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, Gu LZ, Wang HF, Ding ZZ, Zhang YD, Yu JT (2014) Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39(13):2949\u20132962. doi: 10.1038\/npp.2014.164","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2463_CR324","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL, Cotleur AC, Butovsky O, Bekris L, Staugaitis SM, Leverenz JB, Pimplikar SW, Landreth GE, Howell GR, Ransohoff RM, Lamb BT (2015) TREM2 deficiency eliminates TREM2 + inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. J Exp Med 212(3):287\u2013295. doi: 10.1084\/jem.20142322","journal-title":"J Exp Med"},{"key":"2463_CR325","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606370","author":"X Xiang","year":"2016","unstructured":"Xiang X, Werner G, Bohrmann B, Liesz A, Mazaheri F, Capell A, Feederle R, Knuesel I, Kleinberger G, Haass C (2016) TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance. EMBO Mol Med. doi: 10.15252\/emmm.201606370","journal-title":"EMBO Mol Med"},{"key":"2463_CR326","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/ncomms3030","volume":"4","author":"D Frenkel","year":"2013","unstructured":"Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, Farfara D, Kingery ND, Weiner HL, El Khoury J (2013) Scara1 deficiency impairs clearance of soluble amyloid-beta by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression. Nature Commun 4:2030. doi: 10.1038\/ncomms3030","journal-title":"Nature Commun"},{"issue":"2","key":"2463_CR327","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11481-006-9049-8","volume":"2","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto M, Kiyota T, Walsh SM, Ikezu T (2007) Kinetic analysis of aggregated amyloid-beta peptide clearance in adult bone-marrow-derived macrophages from APP and CCL2 transgenic mice. J Neuroimmune Pharmacol 2(2):213\u2013221. doi: 10.1007\/s11481-006-9049-8","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"2463_CR328","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1073\/pnas.0805453106","volume":"106","author":"CA Hawkes","year":"2009","unstructured":"Hawkes CA, McLaurin J (2009) Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci USA 106(4):1261\u20131266. doi: 10.1073\/pnas.0805453106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2463_CR329","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","volume":"5","author":"JP Michaud","year":"2013","unstructured":"Michaud JP, Bellavance MA, Prefontaine P, Rivest S (2013) Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep 5(3):646\u2013653. doi: 10.1016\/j.celrep.2013.10.010","journal-title":"Cell Rep"},{"issue":"31","key":"2463_CR330","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1523\/jneurosci.6209-10.2011","volume":"31","author":"A Mildner","year":"2011","unstructured":"Mildner A, Schlevogt B, Kierdorf K, Bottcher C, Erny D, Kummer MP, Quinn M, Bruck W, Bechmann I, Heneka MT, Priller J, Prinz M (2011) Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer\u2019s disease. J Neurosci 31(31):11159\u201311171. doi: 10.1523\/jneurosci.6209-10.2011","journal-title":"J Neurosci"},{"issue":"16","key":"2463_CR331","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1523\/jneurosci.0299-11.2011","volume":"31","author":"G Naert","year":"2011","unstructured":"Naert G, Rivest S (2011) CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 31(16):6208\u20136220. doi: 10.1523\/jneurosci.0299-11.2011","journal-title":"J Neurosci"},{"issue":"3","key":"2463_CR332","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nbd.2011.01.005","volume":"42","author":"CN Yang","year":"2011","unstructured":"Yang CN, Shiao YJ, Shie FS, Guo BS, Chen PH, Cho CY, Chen YJ, Huang FL, Tsay HJ (2011) Mechanism mediating oligomeric Abeta clearance by naive primary microglia. Neurobiol Dis 42(3):221\u2013230. doi: 10.1016\/j.nbd.2011.01.005","journal-title":"Neurobiol Dis"},{"issue":"13","key":"2463_CR333","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1523\/jneurosci.5572-08.2009","volume":"29","author":"S Mandrekar","year":"2009","unstructured":"Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29(13):4252\u20134262. doi: 10.1523\/jneurosci.5572-08.2009","journal-title":"J Neurosci"},{"issue":"44","key":"2463_CR334","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1523\/jneurosci.2557-04.2004","volume":"24","author":"J Koenigsknecht","year":"2004","unstructured":"Koenigsknecht J, Landreth G (2004) Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J Neurosci 24(44):9838\u20139846. doi: 10.1523\/jneurosci.2557-04.2004","journal-title":"J Neurosci"},{"issue":"11","key":"2463_CR335","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl SA, Kalin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M (2009) Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12(11):1361\u20131363. doi: 10.1038\/nn.2432","journal-title":"Nat Neurosci"},{"key":"2463_CR336","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.07.003","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Green KN (2016) Inflammation in Alzheimer\u2019s disease: Lessons learned from microglia-depletion models. Brain Behav Immun. doi: 10.1016\/j.bbi.2016.07.003","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2463_CR337","doi-asserted-by":"publisher","first-page":"e60921","DOI":"10.1371\/journal.pone.0060921","volume":"8","author":"G Krabbe","year":"2013","unstructured":"Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, Miller KR, Prokop S, Kettenmann H, Heppner FL (2013) Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PloS One 8(4):e60921. doi: 10.1371\/journal.pone.0060921","journal-title":"PloS One"},{"issue":"16","key":"2463_CR338","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1523\/jneurosci.4814-07.2008","volume":"28","author":"T Bolmont","year":"2008","unstructured":"Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE, Kohsaka S, Jucker M, Calhoun ME (2008) Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28(16):4283\u20134292. doi: 10.1523\/jneurosci.4814-07.2008","journal-title":"J Neurosci"},{"key":"2463_CR339","doi-asserted-by":"publisher","first-page":"14624","DOI":"10.1038\/srep14624","volume":"5","author":"S Hellwig","year":"2015","unstructured":"Hellwig S, Masuch A, Nestel S, Katzmarski N, Meyer-Luehmann M, Biber K (2015) Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-beta plaque formation in organotypic hippocampal slice cultures. Sci Rep 5:14624. doi: 10.1038\/srep14624","journal-title":"Sci Rep"},{"issue":"1","key":"2463_CR340","doi-asserted-by":"publisher","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2(1):a006346. doi: 10.1101\/cshperspect.a006346","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"2463_CR341","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O\u2019Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21(3):383\u2013421","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2463_CR342","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9440(10)65542-3","volume":"153","author":"MQ Xia","year":"1998","unstructured":"Xia MQ, Qin SX, Wu LJ, Mackay CR, Hyman BT (1998) Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer\u2019s disease brains. Am J Pathol 153(1):31\u201337","journal-title":"Am J Pathol"},{"issue":"30","key":"2463_CR343","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.M600504200","volume":"281","author":"H Takeuchi","year":"2006","unstructured":"Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T, Suzumura A (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281(30):21362\u201321368. doi: 10.1074\/jbc.M600504200","journal-title":"J Biol Chem"},{"issue":"3","key":"2463_CR344","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease\u2013a double-edged sword. Neuron 35(3):419\u2013432","journal-title":"Neuron"},{"issue":"4","key":"2463_CR345","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/nen.0000000000000176","volume":"74","author":"I Lopez-Gonzalez","year":"2015","unstructured":"Lopez-Gonzalez I, Schluter A, Aso E, Garcia-Esparcia P, Ansoleaga B, F LL, Carmona M, Moreno J, Fuso A, Portero-Otin M, Pamplona R, Pujol A, Ferrer I (2015) Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species. J Neuropathol Exp Neurol 74(4):319\u2013344. doi: 10.1097\/nen.0000000000000176","journal-title":"J Neuropathol Exp Neurol"},{"issue":"27","key":"2463_CR346","doi-asserted-by":"publisher","first-page":"9977","DOI":"10.1523\/jneurosci.0336-15.2015","volume":"35","author":"RA Rice","year":"2015","unstructured":"Rice RA, Spangenberg EE, Yamate-Morgan H, Lee RJ, Arora RP, Hernandez MX, Tenner AJ, West BL, Green KN (2015) Elimination of microglia improves functional outcomes following extensive neuronal loss in the hippocampus. J Neurosci 35(27):9977\u20139989. doi: 10.1523\/jneurosci.0336-15.2015","journal-title":"J Neurosci"},{"key":"2463_CR347","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww016","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MR, Blurton-Jones M, West BL, Green KN (2016) Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology. Brain J Neurol 139(Pt 4):1265\u20131281. doi: 10.1093\/brain\/aww016","journal-title":"Brain J Neurol"},{"issue":"31","key":"2463_CR348","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1073\/pnas.0604681103","volume":"103","author":"O Butovsky","year":"2006","unstructured":"Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, Schwartz M (2006) Glatiramer acetate fights against Alzheimer\u2019s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA 103(31):11784\u201311789. doi: 10.1073\/pnas.0604681103","journal-title":"Proc Natl Acad Sci USA"},{"key":"2463_CR349","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J (2015) Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nature Commun 6:6176. doi: 10.1038\/ncomms7176","journal-title":"Nature Commun"},{"issue":"7632","key":"2463_CR350","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, Mathys H, Seo J, Kritskiy O, Abdurrob F, Adaikkan C, Canter RG, Rueda R, Brown EN, Boyden ES, Tsai LH (2016) Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540(7632):230\u2013235. doi: 10.1038\/nature20587","journal-title":"Nature"},{"key":"2463_CR351","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv066","author":"MA Michell-Robinson","year":"2015","unstructured":"Michell-Robinson MA, Touil H, Healy LM, Owen DR, Durafourt BA, Bar-Or A, Antel JP, Moore CS (2015) Roles of microglia in brain development, tissue maintenance and repair. Brain J Neurol 138(Pt 5):1138\u20131159. doi: 10.1093\/brain\/awv066","journal-title":"Brain J Neurol"},{"issue":"12","key":"2463_CR352","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/nn2015","volume":"10","author":"A Mildner","year":"2007","unstructured":"Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Bruck W, Priller J, Prinz M (2007) Microglia in the adult brain arise from Ly-6ChiCCR2 + monocytes only under defined host conditions. Nat Neurosci 10(12):1544\u20131553. doi: 10.1038\/nn2015","journal-title":"Nat Neurosci"},{"issue":"11","key":"2463_CR353","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1084\/jem.20150479","volume":"212","author":"S Prokop","year":"2015","unstructured":"Prokop S, Miller KR, Drost N, Handrick S, Mathur V, Luo J, Wegner A, Wyss-Coray T, Heppner FL (2015) Impact of peripheral myeloid cells on amyloid-beta pathology in Alzheimer\u2019s disease-like mice. J Exp Med 212(11):1811\u20131818. doi: 10.1084\/jem.20150479","journal-title":"J Exp Med"},{"issue":"11","key":"2463_CR354","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1084\/jem.20150478","volume":"212","author":"NH Varvel","year":"2015","unstructured":"Varvel NH, Grathwohl SA, Degenhardt K, Resch C, Bosch A, Jucker M, Neher JJ (2015) Replacement of brain-resident myeloid cells does not alter cerebral amyloid-beta deposition in mouse models of Alzheimer\u2019s disease. J Exp Med 212(11):1803\u20131809. doi: 10.1084\/jem.20150478","journal-title":"J Exp Med"},{"issue":"12","key":"2463_CR355","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/nn2014","volume":"10","author":"B Ajami","year":"2007","unstructured":"Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM (2007) Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10(12):1538\u20131543. doi: 10.1038\/nn2014","journal-title":"Nat Neurosci"},{"issue":"2","key":"2463_CR356","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-008-0481-0","volume":"117","author":"J Zaghi","year":"2009","unstructured":"Zaghi J, Goldenson B, Inayathullah M, Lossinsky AS, Masoumi A, Avagyan H, Mahanian M, Bernas M, Weinand M, Rosenthal MJ, Espinosa-Jeffrey A, de Vellis J, Teplow DB, Fiala M (2009) Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy. Acta Neuropathol (Berl) 117(2):111\u2013124. doi: 10.1007\/s00401-008-0481-0","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"2463_CR357","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO;2-B","volume":"43","author":"MD Ard","year":"1996","unstructured":"Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD (1996) Scavenging of Alzheimer\u2019s amyloid beta-protein by microglia in culture. J Neurosci Res 43(2):190\u2013202. doi: 10.1002\/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO;2-B","journal-title":"J Neurosci Res"},{"issue":"6","key":"2463_CR358","first-page":"1389","volume":"140","author":"SA Frautschy","year":"1992","unstructured":"Frautschy SA, Cole GM, Baird A (1992) Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol 140(6):1389\u20131399","journal-title":"Am J Pathol"},{"issue":"6","key":"2463_CR359","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1523\/JNEUROSCI.18-06-02161.1998","volume":"18","author":"DT Weldon","year":"1998","unstructured":"Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O\u2019Hare E, Esler WP, Maggio JE, Mantyh PW (1998) Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 18(6):2161\u20132173","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"2463_CR360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(96)12474-5","volume":"206","author":"H Akiyama","year":"1996","unstructured":"Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL (1996) Granules in glial cells of patients with Alzheimer\u2019s disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neurosci Lett 206(2\u20133):169\u2013172","journal-title":"Neurosci Lett"},{"issue":"40","key":"2463_CR361","doi-asserted-by":"publisher","first-page":"34914","DOI":"10.1074\/jbc.M111.232116","volume":"286","author":"K Wilkinson","year":"2011","unstructured":"Wilkinson K, Boyd JD, Glicksman M, Moore KJ, El Khoury J (2011) A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36. J Biol Chem 286(40):34914\u201334922. doi: 10.1074\/jbc.M111.232116","journal-title":"J Biol Chem"},{"issue":"2","key":"2463_CR362","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1471-4159.2007.05001.x","volume":"104","author":"ML Udan","year":"2008","unstructured":"Udan ML, Ajit D, Crouse NR, Nichols MR (2008) Toll-like receptors 2 and 4 mediate Abeta(1\u201342) activation of the innate immune response in a human monocytic cell line. J Neurochem 104(2):524\u2013533. doi: 10.1111\/j.1471-4159.2007.05001.x","journal-title":"J Neurochem"},{"issue":"38","key":"2463_CR363","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1523\/jneurosci.3158-09.2009","volume":"29","author":"EG Reed-Geaghan","year":"2009","unstructured":"Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci 29(38):11982\u201311992. doi: 10.1523\/jneurosci.3158-09.2009","journal-title":"J Neurosci"},{"issue":"2","key":"2463_CR364","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/eji.1830250224","volume":"25","author":"DA Hughes","year":"1995","unstructured":"Hughes DA, Fraser IP, Gordon S (1995) Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur J Immunol 25(2):466\u2013473. doi: 10.1002\/eji.1830250224","journal-title":"Eur J Immunol"},{"issue":"6593","key":"2463_CR365","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/382716a0","volume":"382","author":"J El Khoury","year":"1996","unstructured":"El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382(6593):716\u2013719. doi: 10.1038\/382716a0","journal-title":"Nature"},{"issue":"6","key":"2463_CR366","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/00001756-200105080-00020","volume":"12","author":"H Chung","year":"2001","unstructured":"Chung H, Brazil MI, Irizarry MC, Hyman BT, Maxfield FR (2001) Uptake of fibrillar beta-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice. Neuroreport 12(6):1151\u20131154","journal-title":"Neuroreport"},{"issue":"12","key":"2463_CR367","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1167\/iovs.11-7498","volume":"52","author":"S Bakalash","year":"2011","unstructured":"Bakalash S, Pham M, Koronyo Y, Salumbides BC, Kramerov A, Seidenberg H, Berel D, Black KL, Koronyo-Hamaoui M (2011) Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer\u2019s disease. Investig Ophthalmol Vis Sci 52(12):9033\u20139046. doi: 10.1167\/iovs.11-7498","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2463_CR368","doi-asserted-by":"publisher","first-page":"489456","DOI":"10.1155\/2012\/489456","volume":"2012","author":"K Wilkinson","year":"2012","unstructured":"Wilkinson K, El Khoury J (2012) Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer\u2019s disease. Int J Alzheimers Dis 2012:489456. doi: 10.1155\/2012\/489456","journal-title":"Int J Alzheimers Dis"},{"issue":"1","key":"2463_CR369","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9440(10)63945-4","volume":"158","author":"KD Bornemann","year":"2001","unstructured":"Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, Sommer B, Jucker M, Staufenbiel M (2001) Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol 158(1):63\u201373","journal-title":"Am J Pathol"},{"issue":"2","key":"2463_CR370","first-page":"399","volume":"148","author":"RH Christie","year":"1996","unstructured":"Christie RH, Freeman M, Hyman BT (1996) Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer\u2019s disease. Am J Pathol 148(2):399\u2013403","journal-title":"Am J Pathol"},{"issue":"1","key":"2463_CR371","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10571-014-0101-6","volume":"35","author":"Y Yu","year":"2015","unstructured":"Yu Y, Ye RD (2015) Microglial Abeta receptors in Alzheimer\u2019s disease. Cell Mol Neurobiol 35(1):71\u201383. doi: 10.1007\/s10571-014-0101-6","journal-title":"Cell Mol Neurobiol"},{"issue":"12","key":"2463_CR372","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20021546","volume":"197","author":"JB El Khoury","year":"2003","unstructured":"El Khoury JB, Moore KJ, Means TK, Leung J, Terada K, Toft M, Freeman MW, Luster AD (2003) CD36 mediates the innate host response to beta-amyloid. J Exp Med 197(12):1657\u20131666. doi: 10.1084\/jem.20021546","journal-title":"J Exp Med"},{"issue":"8","key":"2463_CR373","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA, Moore KJ (2013) CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14(8):812\u2013820. doi: 10.1038\/ni.2639","journal-title":"Nat Immunol"},{"key":"2463_CR374","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-6-45","volume":"6","author":"XD Pan","year":"2011","unstructured":"Pan XD, Zhu YG, Lin N, Zhang J, Ye QY, Huang HP, Chen XC (2011) Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer\u2019s disease. Mol Neurodegener 6:45. doi: 10.1186\/1750-1326-6-45","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2463_CR375","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","volume":"171","author":"MR Daws","year":"2003","unstructured":"Daws MR, Sullam PM, Niemi EC, Chen TT, Tchao NK, Seaman WE (2003) Pattern recognition by TREM-2: binding of anionic ligands. J Immunol (Baltimore, Md: 1950) 171 (2):594\u2013599","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"6","key":"2463_CR376","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, Holtzman DM, Cirrito JR, Colonna M (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160(6):1061\u20131071. doi: 10.1016\/j.cell.2015.01.049","journal-title":"Cell"},{"issue":"2","key":"2463_CR377","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91(2):328\u2013340. doi: 10.1016\/j.neuron.2016.06.015","journal-title":"Neuron"},{"issue":"8","key":"2463_CR378","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","volume":"194","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Hernandez-Munain C, Cella M, Colonna M (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 194(8):1111\u20131122","journal-title":"J Exp Med"},{"issue":"33","key":"2463_CR379","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.1523\/jneurosci.1224-13.2013","volume":"33","author":"M Malik","year":"2013","unstructured":"Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S (2013) CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing. J Neurosci 33(33):13320\u201313325. doi: 10.1523\/jneurosci.1224-13.2013","journal-title":"J Neurosci"},{"key":"2463_CR380","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev-immunol-020711-075018","volume":"30","author":"S Pillai","year":"2012","unstructured":"Pillai S, Netravali IA, Cariappa A, Mattoo H (2012) Siglecs and immune regulation. Annu Rev Immunol 30:357\u2013392. doi: 10.1146\/annurev-immunol-020711-075018","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2463_CR381","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1139\/y02-070","volume":"80","author":"M Diserbo","year":"2002","unstructured":"Diserbo M, Agin A, Lamproglou I, Mauris J, Staali F, Multon E, Amourette C (2002) Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study. Can J Physiol Pharmacol 80(7):670\u2013678","journal-title":"Can J Physiol Pharmacol"},{"issue":"1\u20132","key":"2463_CR382","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2004.06.058","volume":"1022","author":"J Wegiel","year":"2004","unstructured":"Wegiel J, Imaki H, Wang KC, Wegiel J, Rubenstein R (2004) Cells of monocyte\/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res 1022(1\u20132):19\u201329. doi: 10.1016\/j.brainres.2004.06.058","journal-title":"Brain Res"},{"issue":"4","key":"2463_CR383","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-002-0660-3","volume":"105","author":"J Wegiel","year":"2003","unstructured":"Wegiel J, Imaki H, Wang KC, Wegiel J, Wronska A, Osuchowski M, Rubenstein R (2003) Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol (Berl) 105(4):393\u2013402. doi: 10.1007\/s00401-002-0660-3","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"2463_CR384","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29(6):313\u2013326. doi: 10.1089\/jir.2008.0027","journal-title":"J Interferon Cytokine Res"},{"issue":"1\u20132","key":"2463_CR385","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jneuroim.2010.05.010","volume":"224","author":"G Conductier","year":"2010","unstructured":"Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C (2010) The role of monocyte chemoattractant protein MCP1\/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224(1\u20132):93\u2013100. doi: 10.1016\/j.jneuroim.2010.05.010","journal-title":"J Neuroimmunol"},{"issue":"1\u20133","key":"2463_CR386","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/bf02816103","volume":"9","author":"LS Perlmutter","year":"1994","unstructured":"Perlmutter LS (1994) Microvascular pathology and vascular basement membrane components in Alzheimer\u2019s disease. Mol Neurobiol 9(1\u20133):33\u201340. doi: 10.1007\/bf02816103","journal-title":"Mol Neurobiol"},{"issue":"6","key":"2463_CR387","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1600-0404.2007.00823.x","volume":"115","author":"A Algotsson","year":"2007","unstructured":"Algotsson A, Winblad B (2007) The integrity of the blood-brain barrier in Alzheimer\u2019s disease. Acta Neurol Scand 115(6):403\u2013408. doi: 10.1111\/j.1600-0404.2007.00823.x","journal-title":"Acta Neurol Scand"},{"issue":"21","key":"2463_CR388","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","volume":"68","author":"GL Bowman","year":"2007","unstructured":"Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF (2007) Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68(21):1809\u20131814. doi: 10.1212\/01.wnl.0000262031.18018.1a","journal-title":"Neurology"},{"issue":"3","key":"2463_CR389","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4049\/jimmunol.157.3.1213","volume":"157","author":"L Meda","year":"1996","unstructured":"Meda L, Bernasconi S, Bonaiuto C, Sozzani S, Zhou D, Otvos L, Jr., Mantovani A, Rossi F, Cassatella MA (1996) Beta-amyloid (25\u201335) peptide and IFN-gamma synergistically induce the production of the chemotactic cytokine MCP-1\/JE in monocytes and microglial cells. J Immunol (Baltimore, Md: 1950) 157 (3):1213\u20131218","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"2463_CR390","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fncel.2013.00034","volume":"7","author":"A London","year":"2013","unstructured":"London A, Cohen M, Schwartz M (2013) Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci 7:34. doi: 10.3389\/fncel.2013.00034","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"2463_CR391","doi-asserted-by":"publisher","first-page":"e27969","DOI":"10.1371\/journal.pone.0027969","volume":"6","author":"R Shechter","year":"2011","unstructured":"Shechter R, Raposo C, London A, Sagi I, Schwartz M (2011) The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PloS One 6(12):e27969. doi: 10.1371\/journal.pone.0027969","journal-title":"PloS One"},{"issue":"7","key":"2463_CR392","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1096\/fj.04-3104com","volume":"19","author":"D Huang","year":"2005","unstructured":"Huang D, Wujek J, Kidd G, He TT, Cardona A, Sasse ME, Stein EJ, Kish J, Tani M, Charo IF, Proudfoot AE, Rollins BJ, Handel T, Ransohoff RM (2005) Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J 19(7):761\u2013772. doi: 10.1096\/fj.04-3104com","journal-title":"FASEB J"},{"issue":"1","key":"2463_CR393","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Zlokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targ 8(1):16\u201330","journal-title":"CNS Neurol Disord Drug Targ"},{"issue":"9","key":"2463_CR394","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, Khanna P, Jain SC, Thakur SS, Ravindranath V (2012) Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA 109(9):3510\u20133515. doi: 10.1073\/pnas.1112209109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7362","key":"2463_CR395","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477(7362):90\u201394. doi: 10.1038\/nature10357","journal-title":"Nature"},{"issue":"6","key":"2463_CR396","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nm.3569","volume":"20","author":"SA Villeda","year":"2014","unstructured":"Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, Smith LK, Bieri G, Lin K, Berdnik D, Wabl R, Udeochu J, Wheatley EG, Zou B, Simmons DA, Xie XS, Longo FM, Wyss-Coray T (2014) Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med 20(6):659\u2013663. doi: 10.1038\/nm.3569","journal-title":"Nat Med"},{"issue":"4","key":"2463_CR397","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu XL, Liu YH, Zhu C, Shen LL, Jiao SS, Zhu XY, Giunta B, Tan J, Song WH, Zhou HD, Zhou XF, Wang YJ (2015) Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol (Berl) 130(4):487\u2013499. doi: 10.1007\/s00401-015-1477-1","journal-title":"Acta Neuropathol (Berl)"},{"issue":"7","key":"2463_CR398","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280(7):5892\u20135901. doi: 10.1074\/jbc.M404751200","journal-title":"J Biol Chem"},{"issue":"1","key":"2463_CR399","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2006-10101","volume":"10","author":"L Zhang","year":"2006","unstructured":"Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M (2006) Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer\u2019s disease patients. JAD 10(1):1\u20137","journal-title":"JAD"},{"issue":"2","key":"2463_CR400","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch K, Deczkowska A, Rosenzweig N, Tsitsou-Kampeli A, Sharif AM, Matcovitch-Natan O, Kertser A, David E, Amit I, Schwartz M (2016) PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med 22(2):135\u2013137. doi: 10.1038\/nm.4022","journal-title":"Nat Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2463-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:29:12Z","timestamp":1692671352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2463-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":400,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2463"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2463-7","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}